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ABSTRACT 
ATP has been shown to be a sympathetic neurotransmitter in blood vessels. 
However, its relative importance has been shown to be influenced by the 
experimental conditions employed such as alteration of the vascular tone. Thus 
the main aim was to raise the tone of vascular preparations and to further 
examine sympathetic neurotransmission in these preparations. Porcine whole 
mesenteries were perfused with physiological buffer and changes in pressure 
recorded or different sized mesenteric arteries were isolated and set up for 
isometric recording.  
Responses to electrical field stimulation (EFS) were obtained under basal and 
raised tone conditions induced by U46619, a thromboxane A2 mimetic. The 
nature of the neurotransmitters involved in the mediation of the electrically-
evoked responses was assessed using an Į1-adrenoceptor antagonist, prazosin 
DQGRU WKH 3; UHFHSWRU GHVHQVLWL]LQJ DJHQW Įȕ-methyleneATP, an Į2-
adrenoceptor RX811059 antagonist, and a neuropeptide Y Y1 receptor 
antagonist BIBP3226. In separate experiments, responses to nerve stimulation 
were investigated in rat mesenteric small arteries pressurized to 90 mmHg. The 
effects of a VHOHFWLYH Į1-adrenoceptor antagonist, YM-12617, and selective 
P2X1 receptor antagonist, NF-449, on the electrically-evoked response were 
determined.  
Under basal tone conditions the electrically-evoked contractile responses in 
porcine whole mesenteric bed and isolated arteries were exclusively mediated 
by noradrenaline (NA) since they were inhibited by prazosin. However, under 
conditions of raised tone, the electrically-evoked responses were enhanced and 
a role for ATP was evident since these responses ZHUH VHQVLWLYH WR Įȕ-
methyleneATP. RHVSRQVHVWRH[RJHQRXV1$DQGĮȕ-methyleneATP were also 
enhanced at raised tone indicating a postjunctional mechanism of 
enhancement. Nifedipine attenuated the enhanced responses to EFS DQG Įȕ-
methyleneATP suggesting a possible role for L-type calcium channels in the 
mediation of the enhanced responses. In rat pressurised mesenteric arteries the 
electrically-evoked vasocontractile responses were sensitive to YM-12617 and 
NF-449, indicating that NA and ATP were involved in the mediation of these 
responses. Raising tone with U46619 in these arteries enhanced the 
electrically-evoked contractile response; under these conditions responses were 
sensitive to both YM-12617 and NF-449.  
The present study supports the observation that ATP becomes a more 
important sympathetic neurotransmitter under conditions of raised tone in 
contrast to when tone is absent. In porcine mesenteric vascular preparations 
NA predominates as the main sympathetic neurotransmitter under conditions 
of basal tone. However, when tone was raised the responses were enhanced 
and a role for ATP became evident.  
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1 GENERAL INTRODUCTION 
1.1 ROLE OF BLOOD VESSELS IN THE REGULATION 
OF SYSTEMIC BLOOD PRESSURE 
Systemic blood pressure is the product of the cardiac output and systemic 
peripheral vascular resistance. The homeostatic systems that influence blood 
pressure are neural regulation, arterial baroreceptors and chemoreceptors, 
regulation of fluid volume, and humoral regulation (Guyton, 2005). Apart from 
the regulation of fluid volume, which is mainly controlled by the action of the 
kidneys, other factors that regulate systemic blood pressure mainly target 
blood vessels, with small arteries being crucial in the control of peripheral 
resistance and hence in regulating blood pressure. Blood vessels diameter is 
controlled by the three layers that compose the blood vessels. The innermost 
layer of blood vessels, which is called the endothelium, can actively contribute 
to the contractile status of blood vessels by releasing several biologically 
active substances including nitric oxide (NO) (Furchgott et al., 1984), 
prostacyclin (Moncada et al., 1979), as well as endothelium derived 
hyperpolarizing factor (EDHF) (Taylor and Weston, 1988). The outermost 
layer of blood vessels, called the adventitia, contains perivascular nerves which 
are usually of two types; sympathetic and sensory (also called sensory-motor 
or capsaicin-sensitive sensory nerves). Both mediate their functions by 
releasing different neurotransmitters. Between the endothelial and adventitial 
layers is a layer of smooth muscle cells which responds to the different signals 
released from endothelium and perivascular nerves in the adventitia to enable 
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the blood vessel to alter its diameter. Thus the function of blood vessels is 
under a dual regulation of endothelium and perivascular nerves (Burnstock, 
1990). Furthermore, blood vessels are also regulated by hormones within the 
blood and formed elements of blood such as red blood cells (RBC). RBC act as 
a sensor for hypoxia thus when O2 levels become low RBC release adenosine 
triphosphate (ATP) which stimulates vasodilatation (Dietrich et al., 2000). 
Therefore, blood vessel contractility is orchestrated by endothelium, blood 
borne factors and perivascular nerves. 
However, another mechanism which has been shown to be involved in the 
regulation of blood flow is the ability of small arteries, especially arterioles, to 
develop myogenic tone (MT) (Johnson, 1981). MT is the ability of small blood 
vessels to constrict in response to increases in intraluminal pressure or to relax 
in response to decreases in blood pressure regardless of the neuronal, hormonal 
and metabolic influences (Davis and Hill, 1999). 
1.2 PERIVASCULAR NERVES 
1.2.1 SENSORY NERVES 
Blood vessels are innervated by sensory nerves in addition to sympathetic 
nerves. These nerves are called sensory-motor or capsaicin-sensitive sensory 
nerves due to their sensitivity to capsaicin, the active ingredient of chilli pepper 
(Holzer, 1991a). The common conception about sensory nerves in general is 
that they convey information from the periphery to the central nervous system. 
Interestingly in some organs including blood vessels it has been demonstrated 
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that sensory-motor nerves act as effector neurons by releasing neuropeptides 
which act as neurotransmitters to alter vascular diameter and hence control 
blood flow (Maggi and Meli, 1988). The peptides include calcitonin gene-
related peptide (CGRP), substance P and neurokinin A (NKA). Their release 
has been demonstrated in several blood vessels. For example, stimulation of 
the perivascular nerves of rat mesenteric arteries causes the release of CGRP 
which causes vasorelaxation (Kawasaki et al., 1988). The function of sensory-
motor nerves can be divided into local effects, achieved by the release of 
neurotransmitters (Holzer, 1991b), and central effects through different 
reflexes, including thermoregulatory, neuroendocrine and cardiovascular, to 
maintain body homeostasis (Rubino and Burnstock, 1996). It has previously 
been shown that depletion of sensory afferent nerves of their neurotransmitters 
using capsaicin, enhanced the response to electrical field stimulation (EFS) in 
the rat isolated mesenteric vascular bed (Li and Duckles, 1992). Similar 
observation has also been reported recently in the rat isolated mesenteric 
vascular bed (Pakdeechote et al., 2007), most likely as a result of allowing 
sympathetic nerves to mediate the responses without functional antagonism 
from sensory nerves (Ralevic and Kendall, 2002). 
1.2.2 Sympathetic nerves 
Each sympathetic nerve stores catecholamines in its terminal vesicles, and 
since catecholamines react with formaldehyde to become highly fluorescent, 
the identification of catecholamines in sympathetic nerves in different organs 
and tissues became possible (Falck, 1962). The presence and distribution of 
sympathetic nerves has been demonstrated in different blood vessels in many 
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species, for example, in terminal arterioles of the rat mesentery (Furness, 
1973), pulmonary arteries of the monkey (El-Bermani, 1978), and the superior 
mesenteric artery and vein of rat (Nilsson et al., 1986). Furthermore, the 
retrograde fluorescent dye, fast blue, has also been used to identify sympathetic 
neurons. For example, fast blue revealed sympathetic postganglionic neurons 
supplying mesenteric arteries of the rat (Sheppard, 1986). Recently the 
presence of dense sympathetic innervation in human mesenteric arteries and 
veins has been demonstrated using immunohistochemical staining coupled 
with electron microscopy (Birch et al., 2008). 
1.3 SYMPATHETIC COTRANSMISSION  
Postganglionic sympathetic nerve activation produces biological effects via the 
release of neurotransmitter. Initially, noradrenaline (NA) was considered to be 
the sole neurotransmitter released from sympathetic neurons until the concept 
was challenged by Burnstock who suggested the possible release of more than 
one neurotransmitter from the same neuron (Burnstock, 1976). Since then, 
many studies have shown that neurons can release more than one 
neurotransmitter. For example, adenosine triphosphate (ATP) was proposed by 
Burnstock as a sympathetic neurotransmitter (Burnstock, 1972). Thereafter, it 
was shown that neuropeptide Y (NPY) was also released from sympathetic 
nerves (Lundberg et al., 1983). These discoveries led to the development of the 
concept of cotransmission. 
Cotransmission is now a well established concept in the central and peripheral 
nervous systems. However, many questions remain about the physiological 
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significance of cotransmission. It has been suggested that cotransmission 
allows a synergistic relationship between different neurotransmitters, promotes 
prejunctional neuromodulation and allows differential release of cotransmitter 
during different firing patterns of nerves. An example of a synergistic 
relationship between NA as main transmitter and ATP as a cotransmitter in the 
smooth muscle of rat mesenteric arteries and vas deferens has been shown, and 
it has been suggested that ATP can cooperate with NA to cause smooth muscle 
contraction in a synergistic manner (Ralevic and Burnstock, 1990, Ventura et 
al., 2003). In addition, it has been suggested that one neurotransmitter can lead 
to the sequestration of Ca2+ and thus facilitate the neurotransmission of the 
other neurotransmitter. For example, it has been demonstrated in the mouse 
vas deferens that upon EFS, neuroeffector Ca2+ transients (NCTs) were 
obtained; these NCTs were abolished by the P2X receptor agonist and 
desensitising DJHQWĮȕ-methyleneATP indicating that NCTs were mediated by 
ATP through P2X receptors (Brain et al., 2002b). Later Brain and co-workers 
showed that NCTs led to sequestration of Ca2+ in intracellular stores for 
subsequent Ca2+ release and they suggested that this may provide a mechanism 
for purinergic enhancement of noradrenergic neurotransmission (Brain et al., 
2003). 
It has also been shown that cotransmission promotes more complex patterns of 
presynaptic neuromodulation where the cotransmitter can play an important 
role in the regulation of the release of the main transmitter. NPY for example 
inhibits the release of NA and ATP in the guinea-pig vas deferens (Ellis and 
Burnstock, 1990) or enhances the release of NA in rabbit blood vessels 
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(Edvinsson et al., 1984), even though it has very little direct postjunctional 
effects of its own. Recent studies showed that cotransmission can be involved 
in postjunctional neuromodulation as well. For example, in mouse urinary 
bladder smooth muscle, ATP which is co-released with acetylcholine (Ach) 
suppressed the subsequent muscarinic-mediated increases in excitability and 
force generation via the activation of postsynaptic P2X receptors (Heppner et 
al., 2009). 
Furthermore, it has been shown that NA release is favoured at higher 
frequencies while NPY and ATP release is favoured at lower frequencies of 
EFS in rat tail artery (Bradley et al., 2003), which means that in response to 
different parameters of stimulation the presence of more than neurotransmitter 
would allow different responses of nerves to take place. 
1.3.1 Noradrenaline 
It was originally believed that sympathetic nerves released adrenaline. This 
proposal arose from results obtained in experiments using the perfused rabbit 
ear and frog heart in which the active substance released by adrenergic nerves 
produced similar responses to exogenous adrenaline (Gaddum and 
Kwiatkowski, 1939). However, analysis of homogenised splenic nerves of the 
ox showed the presence of NA in submicroscopic structures of adrenergic 
axons (Hillarp, 1956). In addition, biochemical studies showed the presence of 
enzymes responsible for noradrenaline synthesis in chromaffin cells and 
neurons, and that both tissues were capable of storing and releasing 
catecholamines (Blaschko, 1957). Further experiments demonstrated that NA 
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was formed from tyrosine in homogenates of sympathetic nerve tissue, 
indicating that tyrosine acts as the main precursor of NA synthesis (Goodall 
and Kirshner, 1958). Tyrosine is transported by a noradrenaline linked carrier 
into the exoplasm of adrenergic neurons where it is converted into dopa by 
tyrosine-3-monoxygenase. Thereafter, L -amino acid decarboxylase converts 
dopa to dopamine, and this is transported into sympathetic vesicles where it 
undergoes hydroxylation to form noradrenaline (Blaschko, 1957). Thus, the 
first two steps of NA formation take place outside the storage vesicles while 
the last step occurs inside (Stjarne and Lishajko, 1967). Further studies, using 
cell fractionation, fluorescence and electronmicroscopy methods revealed the 
presence of small and large dense-cored vesicles containing NA in sympathetic 
nerve terminals of rat vas deferens (Bisby and Fillenz, 1970).  
The release of NA from small and large dense-cored vesicles is a Ca2+ 
dependent process following invasion of the nerve varicosity by an action 
potential. It is noteworthy that large vesicles are involved in the release of 
noradrenaline at higher frequencies while the small vesicles are involved at 
lower frequencies (Stjarne, 1989). Direct evidence for the release of NA was 
initially shown using the measurement of tritium released from tissues 
preloaded with 3[H] NA in rabbit main pulmonary artery (Su and Bevan, 
1970). Furthermore, the release of endogenous NA from sympathetic nerves 
has been measured using high performance liquid chromatography in rat tail 
artery (Buchholz and Duckles, 1992), as well as in the rat mesenteric artery 
(Ralevic and Kendall, 2002). The introduction of continuous amperometry, 
which measures the increase in NA concentration at the adventitial surface of 
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the vessel as an oxidation current using carbon fibre electrode (Gonon et al., 
1993), has led to monitoring of the real time of NA release on an impulse-by-
impulse basis in rat tail artery during trains of stimulation (Brock et al., 1997). 
More recent studies in which an amperometric method was used showed that 
WKHUHOHDVHRI1$LVUHJXODWHGE\DFWLYDWLRQRIĮ2-adrenoceptors and suggested 
that the released NA is cleared by diffusion and uptake in sympathetic nerves 
supplying rat mesenteric arteries (Dunn et al., 1999). Moreover, the 
spontaneous packeted release of NA, most likely from large dense-cored 
vesicles has been demonstrated from sympathetic nerve terminals in rat 
mesenteric arteries in vitro (Brock et al., 2000). 
However most of the evidence which indicates that noradrenaline is the main 
sympathetic neurotransmitter has been obtained from pharmacological studies. 
For example, responses to sympathetic nerve stimulation were abolished by the 
Į1-adrenoceptor antagonist prazosin, providing evidence that NA was the main 
neurotransmitter in guinea-pig, rat and rabbit small blood vessels (Angus et al., 
1988). 
1.3.1.1 Adrenoceptors 
In 1906 Dale, noticed some responses to adrenoceptor stimulation which were 
not blocked by classical adrenoceptor antagonists such as ergot alkaloids 
suggesting more than one adrenoceptor existed (Dale, 1906). However it was 
not until 1948 when Ahlquist used different sympathomimetic agonists, that 
the existence of two adrenoceptor subtypes was proposed; one for excitatory 
events, ZKLFK KH FDOOHG Į-adrenoceptors and another for inhibitory events, 
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which he called ȕ-adrenoceptors (Ahlquist, 1948). The discovery of 
dichloroisoprenaline, which was the first ageQW FDSDEOH RI DQWDJRQLVLQJ ȕ-
adrenoceptor-mediated responses selectively, confiUPHG WKH H[LVWHQFH RI Į- 
DQGȕ- subtypes (Powell and Slater, 1958). 
1.3.1.2 ȕ-adrenoceptors 
Because of the greater availability of agonists and antagonLVWV DFWLQJ DW ȕ-
adrenoceptors PDQ\VWXGLHVLQLWLDOO\IRFXVHGRQȕ-adrenoceptors. On the basis 
of different potency to agonists, Lands and co-workers concluded that there 
ZHUH WZR VXEW\SHV RI ȕ-DGUHQRFHSWRUV WKH ȕ1-adrenoceptor (with equal 
sensitivity to both NA and adrenaline and dominance in cardiac and 
JDVWURLQWHVWLQDO WLVVXHV DQG WKH ȕ2-adrenoceptor (with less sensitivity to NA 
and greater presence in vascular, uterine and airway smooth muscles) (Lands et 
al., 1967). 
As more experiments were performed examining ȕ-adrenoceptors, a number of 
tissues were identified which displayed ȕ-adrenoceptor-mediated responses but 
which were relatively unresponsive to ȕ1- DQG ȕ2- agonists. This raised the 
SRVVLELOLW\RIWKHH[LVWHQFHRIDWKLUGȕ-adrenoceptor subtype. The development 
of selective ȕ-adrenoceptor agonists such as BRL 28410 and BRL 37344 has 
VKRZQDW\SLFDOȕ-adrenoceptor expression in some tissues (Arch et al., 1984, 
McLaughlin and MacDonald, 1990). Furthermore, responses to different beta-
adrenergic agonists were studied on adipose cells of the rat using betaxolol (ȕ1-
adrenoceptor selective antagonist) or ICI 118551 (ȕ2-adrenoceptor selective 
antagonist). In this study it has been shown that regulation of lipolysis in 
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adipose tissue was not mediated exclusively by HLWKHUȕ1- RUȕ2-adrenoceptors 
as it was originally assumed. Therefore they proposed D WKLUGȕ-adrenoceptor 
WHUPHGWKHȕ3-adrenoceptor (Tan and Curtis-Prior, 1983). 
There was speculation about the presence of a fourth subt\SH RI ȕ-
adrenoceptor mediating relaxation in rat aorta XVLQJWKHȕ3-adrenoceptor partial 
agonist CGP-12177 (Brawley et al., 2000). However it was demonstrated later 
WKDWWKHȕ4-adrenoceptor does not exist in mice, and it was concluded that the 
effects of CGP-12177 were due to an atypical interaction of this compound 
ZLWKȕ1-adrenoceptors (Kaumann et al., 2001).  
The use of cloning confirmed the presence of the human ȕ1-adrenoceptor 
(Frielle et al., 1987), mammalian ȕ2-adrenoceptor (Dixon et al., 1986) and 
human ȕ3-adrenoceptor (Emorine et al., 1989). Thus, to the best of our 
NQRZOHGJHȕ-adrenoceptRUVDUHRIWKUHHW\SHVȕ1-adrenoceptors responsible for 
WKH UHJXODWLRQ RI FRQWUDFWLOLW\ DQG KHDUW UDWH ȕ2-adrenoceptors mediating 
YDVRGLODWDWLRQ HYRNHG E\ V\PSDWKRPLPHWLF DJRQLVWV DQG ȕ3-adrenoceptors 
which are predominant in adipose tissue and regulate biolysis (Guimaraes and 
Moura, 2001, Alexander, 2009). 
1.3.1.3 Į-adrenoceptors 
In 1957, Brown and Gillespie showed that dibenamine, which is an irreversible 
Į-adrenoceptor antagonist, increased the output of NA in venous blood from 
the cat spleen following nerve stimulation and they suggested that this effect 
ZDV GXH WR EORFNDGH RI SRVWMXQFWLRQDO Į-adrenoceptors. Their reasoning was 
that the released NA could QRWFRPELQHZLWKĮ-adrenoceptors on the effector 
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cells leading to an increase of NA output (Brown and Gillespie, 1957). 
However their conclusions were not consistent with the results of other 
experiments where phenoxybenzamine, whLFKLVDQLUUHYHUVLEOHQRQVSHFLILFĮ-
adrenoceptor blocker, failed to increase the NA output when the reuptake of 
NA had been prevented by cocaine (NA reuptake inhibitor), which indicated 
that the increase of NA output was due to the inhibition of neuronal uptake 
(Thoenen et al., 1964). Furthermore, investigation of the influence of 
unlabelled NA on the release of previously stored 14C-NA in the presence of 
cocaine and phenoxybenzamine in the isolated perfused rabbit heart revealed 
that the extracellular NA inhibited the release of intraneuronal NA evoked by 
nerve stimulation, and this inhibition was mediated by Į-adrenoceptors 
localised on the neuronal membrane. In other words it was shown for the first 
time that NA can inhibit its own release by a feedback mechanism (Starke, 
1972). The availability of certain adrenergic agonists such as clonidine, and 
antagonists such as phenoxybenzamine, helped in discriminating between pre- 
DQGSRVWMXQFWLRQDOĮ-adrenoceptors which led Langer to propose an anatomical 
basis for VXEGLYLVLRQ RI Į-DGUHQRFHSWRUV LQWR WKH SRVWMXQFWLRQDO Į-
adrenoceptor, which mediates effector organ responses, and the prejunctional 
Į-adrenoceptor, which regulates neurotransmitter release (Langer, 1974). 
Later, Berthelsen and Pettinger proposed a functional basis for subdivision of 
Į-adrenoceptors. Accordingly receptors mediating excitation have been termed 
Į1-adrenoceptors while those mediating inhibition were teUPHG Į2-
adrenoceptors (Berthelsen and Pettinger, 1977). 
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However, the development of the higKO\VHOHFWLYHĮ1-adrenoceptor antagonist 
SUD]RVLQ DQG Į2-adrenoceptor antagonist yohimbine enabled Drew and 
Whiting, to demonstrate that the vasoconstrictor responses in rat and cat blood 
vessels were inhibited by prazosin as well as yohimbine, an indication that the 
YDVRFRQVWULFWRU UHVSRQVHV ZHUH PHGLDWHG QRW RQO\ E\ Į1 EXW DOVR E\ Į2 
adrenoceptors (Drew and Whiting, 1979). Thus neither the anatomical nor the 
IXQFWLRQDOFODVVLILFDWLRQIXOILOVWKHWUXWKRIĮ-adrenoceptors. This led Starke to 
propose a new classification based on pharmacological potencies of different 
adrenoceptor agonists and antagonists. 7KXVĮ1-adrenoceptors are activated by 
phenylephrine, meWKR[DPLQHDQGEORFNHGE\SUD]RVLQZKLOHĮ2-adrenoceptors 
are activated by UK-14,304 or BHT933 and blocked by rauwolscine or 
idozoxan (Starke, 1981). 
The use of cloning methods have shown three subtypes of Į1-adrenoceptors; 
Į1A, Į1B DQGĮ1D (Hieble et al., 1995) and three subtypes of Į2-adrenoceptors; 
Į2A Į2B, and Į2C (Kobilka et al., 1987, Regan et al., 1988, Lomasney et al., 
1990). Thus, based on pharmacological potencies of different adrenoceptor 
agonists and antagonists in functional studies and cloning as well as 
radioligand binding data, aW SUHVHQW WKHUH DUH WKUHH VXEW\SHV RI Į1- and Į2-
adrenoceptors. Į1-adrenoceptor subtypes are Į1A Į1B DQG Į1D, while Į2-
adrenoceptor subtypes are Į2AĮ2B, and Į2C (Alexander, 2009). 
The relative importance of the different subtypes RI Į1-adrenoceptors in 
regulation of blood vessel contractility varies between species and vascular 
beds (Guimaraes and Moura, 2001). In addition, activation of different 
subt\SHVRIĮ1-adrenoceptors either by circulating NA or by neurally released 
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NA is another factor that may influence the involvement of different Į1-
adrenoceptors subtypes in the regulation of the of blood vessels contractility. 
For example, NA released from sympathetic nerves in response to EFS, 
DFWLYDWHGĮ1B- DQGLQSDUWĮ1D-adrenoceptors, whereas exogenous NA activated 
Į1A-adrenoceptor in canine splenic arteries (Yang and Chiba, 2001). 
Furthermore, it has been shown that Į1A-adrenoceptors mediated contraction in 
response to both exogenous and neurally released NA while Į1D-adrenoceptors 
were not involved in responses to exogenous NA in rat femoral resistance 
arteries (Zacharia et al., 2004). In contrast, it has been shown that Į1A-
adrenoceptors mediated responses to both exogenous and neurally released NA 
in the isolated perfused mesentery of rat (Williams and Clarke, 1995). 
1.3.1.3.1 Į-adrenoceptors function 
Į1-adrenoceptors are mainly coupled to Gq/11-protein. Their activation 
stimulates phospholipase C enzyme which promotes the hydrolysis of 
phosphatidylinositol 4,5-bisphosphate producing inositol triphosphate (IP3) 
and diacyl glycerol (DAG). IP3 and DAG act as second messengers mediating 
intracellular Ca2+ release from intracellular pools (Zhong and Minneman, 
1999). Į2-adrenoceptors are in general negatively coupled to adenylyl cyclase 
through a Gi-protein (Bylund et al., 1994, Wise et al., 1997), their activation 
causes a reduction in intracellular adenosine 3¶ : 5¶-cyclic mono-phosphate 
(cyclic AMP) production (Roberts et al., 1998). 
In regard to vasculature, SRVWV\QDSWLF Į1-adrenoceptors have been primarily 
shown to mediate contractile responses to sympathetic nerve activation, as 
shown in different blood vessels in different species. For example, electrically-
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evoked contractile UHVSRQVHVZHUHVHQVLWLYHWRĮ1-adrenoceptors antagonism in 
rabbit hindlimb (Madjar et al., 1980), isolated pulmonary artery of the rabbit 
(MacLean et al., 1993), horse penile resistance arteries (Simonsen et al., 1997) 
and guinea-pig mesenteric arteries (Smyth et al., 2000). +RZHYHUDUROHIRUĮ2-
adrenoceptors in mediation of postjunctional responses to the Į2-adrenoceptor 
agonist UK 14304 has been demonstrated in small resistant vessels, for 
example, in human subcutaneous resistance vessels (Nielsen et al., 1989). In 
large conducting arteries on the other hand DFWLYDWLRQ RI Į2-adrenoceptors 
needed experimental manipulation. For example, increasing of perfusion 
pressure by arginine vasopressin in the isolated vascular bed of the rat tail 
(Templeton et al., 1989), or the presence of an unrelated vasoconstrictor such 
as angiotensin II in rabbit isolated distal saphenous artery (Dunn et al., 1989) 
and the presence of U46619 and forskolin in porcine isolated ear artery 
(Roberts et al., 1998). The involvement of postjunctional Į2-adrenoceptors in 
the mediation of neurogenic contractile responses to sympathetic nerve 
activation has also been shown to require experimental manipulation. For 
example, in the presence of angiotensin II the Į2-adrenoceptors antagonist 
rauwolscine inhibited the electrically-evoked responses in the rabbit isolated 
distal saphenous artery (Dunn et al., 1991b). However, a role for Į2-
adrenoceptors in the mediation of the electrically-evoked vasoconstriction 
without experimental manipulation has been shown in the rat tail artery, 
although their involvement was frequency- and train length-dependent (Bao et 
al., 1993). 
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In regard to human blood vessels, in vivo experiments demonstrated the 
presence of postjunctional Į1- and Į2-adrenoceptors by measuring the influence 
on forearm blood flow induced by intra-arterial infusions of selective Į1- and 
Į2-adrenoceptor agonists and antagonists (Jie et al., 1984). In addition, it has 
been shown that presynaptic Į2-adrenoceptors modulate NA release from 
sympathetic nerve endings via a negative feedback mechanism in humans (Jie 
et al., 1987). More recent studies showed the involvement of both 
postjunctional Į1- and Į2-adrenoceptors in the mediation of the electrically-
evoked vasoconstrictor responses in human gastroepiploic artery (Fukui et al., 
2005). 
1.3.2 Adenosine triphosphate (ATP) 
1.3.2.1 ATP structure 
ATP is made of a nitrogenous base (adenine), a sugar (ribose) and a chain of 
three ionised groups (phosphates) bound to the ribose (see Fig. 1.1). However, 
each group is made by an independent metabolic route. In neurons ATP is 
produced by oxidative phosophorylation of glucose which is usually comes 
from the extracellular fluid (Sperlágh and Vizi, 1996). ATP was first identified 
in muscle extracts in 1929 (Fiske and Subbarow, 1929). However, it was 
following identification of its role in the breakdown of glucose to lactic acid 
that marked its role in cellular energy (Lipmann, 1941), and since then ATP 
has been recognised as the source of cellular energy. The recognition of this 
important role led to the belief that ATP could not be an extracellular 
                                                                                                    1. General introduction 
16 
 
transmitter, since it was believed that cells would not sacrifice such an 
important biomolecule for this purpose. 
 
 
 
 
 
 
 
 
 
 
1.3.2.2 ATP storage, release and degradation 
The presence of ATP has been demonstrated in both large and small dense-
cored sympathetic vesicles (Lagercrantz, 1971). Vesicular exocytotic release 
seems to be the mechanism by which ATP is released (Pankratov et al., 2006, 
Pankratov et al., 2007). However there is a debate about the mechanisms 
involved in ATP transport, since ATP is a relatively large molecule that cannot 
pass through the membrane by simple diffusion. Thus, it has been suggested a 
non vesicular ATP release in some cells which may involve ATP-binding 
 
 
 
Fig. 1.1 Diagram shows that The ATP molecule is built up from three chemically different parts A) 
the adenine ring, B) the ribose sugar and C) the triphosphate chain.  
C 
B 
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cassette transporter, plasmalemmal voltage-dependent anion channels and 
connexin or pannexin hemichannels (Scemes et al., 2007). It has been recently 
demonstrated in ATP-secreting cells, that this transporter might be the 
vesicular nucleotide transporter (VNUT) which belongs to the SLC17 anion 
transporter family (Sawada et al., 2008).  
The release of ATP upon depolarizing stimuli has been shown in different 
blood vessels including rabbit pulmonary artery and rat caudal artery (Westfall 
et al., 1987, Takeuchi et al., 1994). In addition, ATP release has been clearly 
demonstrated in cultured sympathetic nerve terminals where tetrodotoxin 
(neurone toxin) inhibited this (Richardson and Brown, 1987, Von Kügelgen et 
al., 1994). The release of ATP upon nerve stimulation has also been shown to 
be a Ca2+-dependent process (Brock and Cunnane, 1999). Using the luciferin-
luciferase assay Kirkpatrick and Burnstock showed the release of ATP from 
sympathetic nerves in the guinea-pig vas deferens (Kirkpatrick and Burnstock, 
1987). An indirect measurement of ATP released from sympathetic nerve 
endings in rat mesenteric arteries was obtained through the recording of the 
excitatory junction potentials (EJPs) from smooth muscles (Brock et al., 2000). 
However, more direct evidence for the release of ATP from the varicosities of 
sympathetic nerves comes from the use of the confocal Ca2+ imaging technique 
where it has been demonstrated that the intermittent release of ATP from nerve 
terminals elicited focal smooth muscle Ca2+ transients in the mouse vas 
deferens (Brain et al., 2002a).  
Once ATP is released into the extracellular fluid, it is regulated by cell surface-
located enzymes named ectonucleotidases. Ectonucleotidases are capable of 
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hydrolyzing ATP to ADP, AMP and adenosine (Gordon, 1986, Zimmermann, 
2006). However, it has been shown that stimulation of sympathetic nerves 
innervating the guinea-pig vas deferens releases not only neuronal ATP, but 
also soluble nucleotidases which led to the breakdown of ATP to adenosine 
(Kennedy et al., 1997, Todorov et al., 1997) 
1.3.2.3 Recognition of ATP as an extracellular neurotransmitter 
In 1960 Burnstock and co-workers obtained inhibitory junction potentials 
(IJPs), hyperpolarisations of smooth muscle produced by stimulation of 
inhibitory nerves, from intestinal smooth muscle as a result of the stimulation 
of noradrenergic noncholinergic (NANC) nerves. The nature of the transmitter 
which was involved in the transmission of the IJPS remained unclear 
(Burnstock and Prosser, 1960). It was not until a decade later that Burnstock 
and co-workers uncovered the nature of the transmitter which was responsible 
for the transmission of IJPs. They investigated the vagal nonadrenergic 
inhibitory responses of guinea-pig and toad stomachs where they showed the 
presence of ATP in the vascular perfusates. Thus, they concluded that ATP 
was the transmitter substance released by nonadrenergic inhibitory nerves 
(Burnstock et al., 1970). Furthermore, it was demonstrated that ATP has 
postjunctional effects on the smooth muscle of vas deferens of guinea-pig 
(Westfall et al., 1978). Subsequent studies showed that neurogenic responses 
in the vas deferens of the guinea pig were blocked by an ATP receptor 
antagonist arylazido aminopropanol ATP (ANAPP3) (Fedan et al., 1981). 
Furthermore, the ATP receptor agonist and desensitizing agent Į,ȕ-
methyleneATP abolished the EJPs obtained to EFS in guinea-pig vas deferens 
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(Sneddon and Burnstock, 1984). However, in blood vessels, it was 
demonstrated that exogenous ATP evoked vasoconstriction followed by 
vasorelaxation in isolated rabbit portal vein (Kennedy and Burnstock, 1985). 
Electrical nerve stimulation produced EJPs that were insensitive to both 
prazosin and yohimbine, while abolished by Įȕ-methyleneATP suggesting 
that ATP was the sole transmitter in rabbit jejunal arteries (Ramme et al., 
1987). Furthermore, Į,ȕ-methyleneATP blocked the neurogenic response in rat 
mesenteric artery (Angus et al., 1988). 
Meanwhile the appearance of cotransmission as a new concept in autonomic 
transmission opened the horizon to further investigate the possibility that ATP 
might be a cotransmitter with noradrenaline in sympathetic neurones, although 
the presence of ATP and catecholamines in specific granules of adrenal 
medulla had been shown as early as 1956 (Carlsson and Hillarp, 1956). 
1.3.2.4 COTRANSMISSION OF ATP AND NORADRENALINE 
The presence of ATP together with NA in both small and large dense-cored 
sympathetic vesicles was demonstrated by Lagercrantz (Lagercrantz, 1971). 
Tritium labelled adenosine and NA were used to investigate the sympathetic 
nerves supplying the rabbit portal vein where it was found that ATP was 
released together with NA (Su, 1975). The presence of ATP as a cotransmitter 
with NA was shown in isolated mesenteric artery of the dog where EFS of the 
perivascular nerves produced responses that were not completely blocked by 
WKH Į1-DGUHQRFHSWRU EORFNHU SUD]RVLQ RU E\ WKH Į2-adrenoceptor blocker 
\RKLPELQHEXWĮȕ-methyleneATP blocked the prazosin resistant component, 
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which gave a strong indication that part of the responses was mediated by ATP 
(Muramatsu, 1986). Furthermore, it has been shown that ATP is a 
cotransmitter with NA in sympathetic nerves of the rabbit hepatic artery 
(Brizzolara and Burnstock, 1990) and in guinea-pig mesenteric veins (Smyth et 
al., 2000).  
The co-existence of ATP and NA in both small and large dense-cored 
sympathetic vesicles has been shown as discussed earlier. However, there have 
been questions to whether NA and ATP were separately released from the 
same subpopulations of sympathetic vesicles or from different subpopulations 
of sympathetic vesicles containing different proportions of NA and ATP. The 
answer to these questions was difficult as there was no unified method to 
measure the simultaneous release of both neurotransmitters. Since NA is 
electrochemically oxidizable (Dunn et al., 1999), whereas ATP is not, 
continuous amperometry has been used successfully in measuring the release 
of NA as it is not sensitive for ATP. Thus, researchers used continuous 
amperometry to measure NA release in combination with recording of the 
intracellular EJPs evoked by ATP as indirect method to measure ATP release 
(Brock and Cunnane, 1993). Results of these experiments showed that the 
release of ATP and NA from sympathetic nerves can be differentially 
modulated by drugs. For H[DPSOH WKH Į2-adrenoceptor antagonist, idazoxan 
had different effects on the oxidation currents produced by NA and EJPs 
evoked by the release of ATP in sympathetic nerves supplying rat mesenteric 
arteries (Dunn et al., 1999).  
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The XVHRIĮ-latrotoxin (which is a peptide that evokes the exocytotic release 
of neurotransmitters from a variety of nerve terminals including sympathetic 
neurones) has shown that the release of NA is most probably from large dense-
cored vesicles; conversely the release of ATP was shown to be from a different 
store, most likely the small dense-cored vesicles in rat mesenteric arteries 
(Brock et al., 2000). The results of these experiments support the differential 
release of NA and ATP. However, using the extracellular recording of 
excitatory junction current (EJC) and the fractional increase in overflow of 
tritium to monitor the per pulse secretion of ATP and [3H] NA from 
sympathetic nerves in guinea-pig vas deferens, Stjärne demonstrated the 
presence of two classes of small vesicles (SVs). The SVs store and release 
either big or small ATP and NA quanta. Furthermore, he suggested that 
different affinity to Ca2+ in the SVs membranes would enable the nerves to 
selectively secrete big quanta at low frequency and small quanta during trains 
at high frequency (Stjarne, 2001). 
New techniques provided direct evidence for cotransmission and co-release of 
ATP and NA. For example, using Ca2+ confocal imaging in vascular smooth 
muscle of rat mesenteric arteries, a novel type of Ca2+ transient (termed a 
junctional Ca2+ transient) occurring early in response to EFS that was followed 
by Ca2+ waves developing later, has been demonstrated (Wier et al., 2009). 
Wier and co-workers suggested that the early junctional Ca2+ transients were 
mediated by ATP and the later Ca2+ waves were mediated by NA. Moreover, 
they suggested that during an early train of nerve stimulation, smooth muscle 
contraction is activated mainly by neurally released ATP from sympathetic 
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varicosities, mainly small vesicles that contain a relatively high concentration 
of ATP and using Ca2+ that has entered via P2X receptors. Later during a train 
of nerve stimulation, NA binds to Į1-adrenoceptors leading to the activation of 
second messenger resulting in the release of Ca2+ from sacroplasmic reticulum 
(SR). At this time, sympathetic varicosities may release small synaptic vesicles 
that contain a relatively high concentration of NA (Lamont et al., 2003, Wier et 
al., 2009).  
In summary, the detection of co-release of ATP and NA in sympathetic nerves 
using amperometric and neurotransmitter overflow methods has shown a 
differential release of ATP and NA, while the use of Ca2+ confocal imaging 
suggest the co-release of packets of these neurotransmitters during low-
frequency nerve stimulation (Brain, 2009). Therefore, ATP and NA synergise 
resulting in a quick and sustainable contraction; ATP is generally released 
during short bursts of sympathetic nerve activation leading to a rapid response 
since P2X receptors are ionotropic channels, whereas prolonged periods of 
activation favour the release of the NA which acts more slowly due to G 
protein coupling and the involvement of second messengers. 
1.3.2.5 Factors affecting ATP as a sympathetic neurotransmitter 
Since the recognition that ATP can act as a sympathetic neurotransmitter or as 
a co-transmitter with NA, it has been difficult to describe its relative functional 
importance. Extensive investigation has shown that the role of ATP can be 
affected by different conditions, including the parameters used for EFS, the 
size of blood vessels studied and experimental conditions used. For example, 
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in rabbit saphenous artery, the responses were monophasic when the electrical 
stimulation period was for 1 s and became biphasic when the stimulation 
period was increased to 1 min. The initial fast phase was mediated by ATP, 
and this was followed by a second slow phase mediated by NA. These 
observations lead to the conclusion that the ratio of ATP to NA released was 
dependent upon the frequency of stimulation (Burnstock and Warland, 1987). 
Furthermore, it has been demonstrated that the purinergic component of 
responses is favoured by relatively short trains of stimuli at lower frequencies 
in small mesenteric arteries of rat (Sjoblom-Widfeldt and Nilsson, 1990).  
The size of the blood vessels has been shown to affect the purinergic response. 
For example, in the rabbit jejunal branches of mesenteric artery and in the 
guinea-pig submucosal arterioles ATP has been shown to be the principal 
transmitter mediating contractile responses in response to EFS, with NA acting 
DV D SUHMXQFWLRQDO QHXURPRGXODWRU WKURXJK Į2-adrenoceptors (Ramme et al., 
1987, Evans and Surprenant, 1992). Furthermore, in rat mesenteric arteries the 
purinergic component becomes larger as the size of the arteries decrease 
(Gitterman and Evans, 2001).  
Experimental conditions can also affect the role of ATP. For example, recent 
studies in rat mesenteric arteries have showed that electrically-evoked 
vasocontractile responses were mediated exclusively by NA under basal tone 
conditions, conversely, ATP contributed as functional neurotransmitter under 
more physiological conditions such as those produced by raising the tone with 
a vasoconstrictor agent (Pakdeechote et al., 2007). Furthermore, raising the 
pressure that arteries experience from 30 mmHg to 90 mmHg, which is close 
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to that experienced by rat mesenteric arteries in vivo, has shown that ATP 
become the dominant neurotransmitter mediating the electrically-evoked 
vasocontractile responses (Rummery et al., 2007). 
1.3.2.6 Purinoceptors 
In 1978 Burnstock was the first to suggest a basis for distinguishing two types 
of purinergic receptors based on three factors, the relative potency to ATP, 
ADP, AMP and adenosine, the effectiveness of methylxanthines as 
antagonists, and finally by their ability to activate adenylate cyclase. Thus, 
according to this classification, receptors where adenosine was the principal 
natural ligand were termed P1 receptors while those receptors where the 
principal ligands were ATP and ADP were termed P2 receptors (Burnstock, 
1978). Subsequently classifications of P2 receptors were made. P2 receptors 
were classified into P2X and P2Y receptors on the basis of the potency of 
VWUXFWXUDO DQDORJXHV RI $73 VXFK DV Įȕ-methyleneATP and the ANPP33 
(Burnstock and Kennedy, 1985). 
Based on this information and on the basis of the molecular structure and 
cloned receptors P2 receptors, are subdivided into two families: ligand-gated 
ion channels mediating fast responses, P2X receptors, and G-protein-coupled 
receptors mediating slow responses, P2Y receptors (Abbracchio and 
Burnstock, 1994, Fredholm et al., 1994, Burnstock, 1996). Significant 
developments in molecular, biochemical and pharmacological techniques have 
led to the further subdivision of purinoceptors. Thus at present P2 receptors are 
divided into two groups, P2X and P2Y. P2X receptors are divided into P2X1, 
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P2X2, P2X3, P2X4, P2X5, P2X6 and P2X7 receptors. The P2Y family is divided 
into P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13 and P2Y14 receptors. P1 
receptors are subdivided into A1, A2A, A2B, and A3 receptors (Ralevic and 
Burnstock, 1998, Alexander, 2009). 
1.3.2.6.1 P2X receptors  
The P2X receptors are trimeric ATP-gated cation channels, which allow the 
entry of Ca2+ in addition to monovalent cations such as Na+ and K+, and small 
organic cations (Benham and Tsien, 1987, Valera et al., 1994). Using 
radioligand assay with [3+@Įȕ-methyleneATP, Bo and Burnstock provided 
direct evidence for the presence of P2X receptors on vascular smooth muscle 
(Bo and Burnstock, 1993). The use of antibodies against the extracellular 
domain of the P2X receptors and against the ubiquitous synaptic vesicle 
proteoglycan (SV2), showed the presence of P2X receptor clusters. Those were 
present on the smooth muscle cells of mesenteric, renal, and pulmonary 
arteries as well as in the aorta and in veins of rat (Hansen et al., 1999). In 
addition, the three-dimensional reconstruction of the P2X and SV2 labelling at 
individual varicosities using confocal microscopy, showed that the varicosities 
were located immediately apposite to the P2X receptor clusters (Hansen et al., 
1999). Data obtained from mouse vas deferens support P2X clustering 
opposite the sympathetic varicosities where anti-P2X combined with anti-SV2 
staining showed that P2X receptor clusters at single sympathetic varicosities 
(Barden et al., 1999). However, other studies have shown that P2X receptors 
are uniformly distributed around the circumference of each smooth muscle cell 
(no clusters), regardless of the existence or the absence of adjacent sympathetic 
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varicosity. For example, immunofluorescence staining of the vas deferens with 
antibodies against P2X receptor showed a diffuse distribution over the entire 
membrane of each smooth muscle cell that was not clustered beneath anti-
SV2-stained sympathetic varicosities on smooth muscle cells of the mouse vas 
deferens (Liang et al., 2001). 
In response to ATP, P2X receptors mediate vasoconstriction (Ralevic and 
Burnstock, 1998). In the vasculature it has been shown that P2X receptor 
activation mediates vasoconstriction in a number of blood vessels including 
rabbit basilar artery (Lee et al., 1976), rat pulmonary vessels (Liu et al., 1989) 
and renal arteries (Inscho et al., 1994). Furthermore, it was shown that the 
postjunctional responses of sympathetic nerve stimulation were solely 
mediated through the activation of P2X purinoceptors in submucosal arterioles 
of the guinea-pig (Evans and Surprenant, 1992). Moreover, in P2X-receptor-
deficient mice, the P2X agonLVWĮȕ-methyleneATP failed to elicit any response 
LQGLFDWLQJ WKH DEVROXWH UHTXLUHPHQWV RI 3; UHFHSWRUV WR PHGLDWH Įȕ-
methyleneATP responses (Lamont et al., 2006). 
With regard to the vasculature the P2X1 receptor, which was cloned in 1994 
(Valera et al., 1994), seems to be more involved in mediating responses to 
ATP as a neurotransmitter than other P2X receptor subtypes. Furthermore, in a 
study characterizing P2X receptor immunoreactivity, it was shown that P2X1 
receptors were expressed in a number of blood vessels including femoral, 
pulmonary, cerebral and renal arteries of the rat (Lewis and Evans, 2001). It 
also has been demonstrated, by immunohistochemical analysis, that the P2X1 
receptor is expressed at high levels in small and medium sized mesenteric 
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arteries from rats (Gitterman and Evans, 2000). Thus it seems, at least in rat 
vasculature, that P2X1 receptors are expressed in almost all blood vessels 
which may be indicative of the relative importance of these receptors in the 
mediation of the purinergic response. In regard to human vasculature the 
presence of P2X1 receptors has been shown using immunohistochemistry in a 
number of blood vessels. For example, P2X1 receptors have been shown in 
postmortem human cerebral arteries (Bo et al., 1998a) and human umbilical 
vessels (Bo et al., 1998b). In addition, on circular and longitudinal smooth 
muscle of human long saphenous vein (Metcalfe et al., 2007). 
P2X1 receptors are also expressed on the endothelium of some human blood 
vessels including the internal mammary artery, radial artery and saphenous 
vein (Ray et al., 2002). It has been suggested that the function of P2X1 
receptors is dependent on its location, inducing contraction when located on 
smooth muscle cells, and dilation when expressed on the endothelium 
(Harrington and Mitchell, 2005). 
However, the presence of other P2X receptors on endothelium has also been 
shown. For example, the presence of P2X2 receptors in small cerebral arteries 
of the rat (Loesch and Burnstock, 2000). Furthermore, P2X4 and P2X5 
receptors were expressed in human endothelial cell monolayers where it has 
been suggested that they are involved in self regulation of endothelial function 
and therefore modulating the vascular tone (Schwiebert et al., 2002). P2X4 and 
P2X6 receptors were also found on human endothelial cells where they have 
been shown to play a role in cell permeability and adhesion through their co-
localisation with the cell adhesion molecule VE-cadherin (Glass et al., 2002). 
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Moreover, P2X4 has also been shown on human vascular endothelial cells 
where their activation resulted in calcium influx (Yamamoto et al., 2000). 
Furthermore, in P2X4 deficient mice, an impaired influx of Ca2+ and 
subsequent production of NO has been reported. Thus, the ability of blood 
vessels to adapt to an acute increase in blood flow by vasodilatation or to adapt 
to chronic decrease in blood flow by vasoconstriction was impaired 
(Yamamoto et al., 2006).  
At present, apart from the P2X6 receptor, it seems that all P2X receptors are 
expressed in the splanchnic circulation at least in arteries, with a strong 
expression of P2X1, P2X4, P2X5 and P2X7 and weak expression of P2X2 and 
P2X3 (Phillips and Hill, 1999). However, even though they may all be present 
functional studies indicate a major role only for P2X1 receptor in mediation of 
the purinergic neurogenic response (Lewis and Evans, 2001).  
1.3.2.6.2 P2Y receptors 
P2Y receptors belong to the family of G-protein-coupled receptors (GPCRs). 
On the basis of the action of their endogenous agonists, P2Y receptors can be 
divided into adenine nucleotide-preferring (P2Y1, P2Y11, P2Y12 and P2Y13) 
and uracil nucleotide-preferring (P2Y2, P2Y4, P2Y6 and P2Y14) receptors (von 
Kugelgen, 2006, Alexander, 2009). Furthermore, according to their G protein 
coupling and second messenger systems P2Y receptors can also be subdivided 
into two groups. One group includes P2Y1, P2Y2, P2Y4, P2Y6 and P2Y11 
receptors which are coupled primarily through members of the Gq/11 family of 
G proteins to activate phospholipase C, resulting in elevation of intracellular 
calcium levels. The other group includes P2Y12, P2Y13 and P2Y14 receptors, 
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which are coupled primarily to inhibition of adenylyl cyclase, resulting in a 
reduced accumulation of cyclic AMP (Ralevic, 2009). 
Generally P2Y receptors are expressed on vascular endothelium where they 
mediate vasorelaxation to purines and pyrimidine nucleotides through 
generation of NO and EDHF (Ralevic, 2009). In regard to human blood vessels 
immunohistochemical staining showed the presence of P2Y2 receptors on the 
endothelium of some human blood vessels including the internal mammary 
artery, radial artery and saphenous vein (Ray et al., 2002). Furthermore, 
immunoreactivity for P2Y1, P2Y2 and P2Y6 receptors has been shown on the 
vascular endothelium of human umbilical vein (Wang et al., 2002). It seems 
that the most dominant functional P2Y receptors which are expressed on 
vascular endothelial cells are P2Y1 (responding to ADP and ATP) and P2Y2 
(similarly sensitive to UTP and ATP) where they act as sensors for shear stress 
and hypoxia in response to locally released purines (Ralevic, 2009). 
However, P2Y receptors can also be found on vascular smooth muscle. For 
example, immunoreactivity to P2Y1, P2Y2, P2Y4 and P2Y6 receptors was 
demonstrated on circular and longitudinal smooth muscle of human long 
saphenous vein (Metcalfe et al., 2007). Functional studies have shown 
evidence for the involvement mainly of P2Y2 and P2Y6 in regulation of blood 
vessels contractility. For example, P2Y2 receptors have been shown to be 
involved
 
in the mediation of contractile responses to uracil nucleotides in 
human coronary arteries (Malmsjo et al., 2000). In addition, P2Y2 and P2Y6 
receptors have also been shown to be involved in the mediation of contractile 
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responses to uracil nucleotides in rat cerebral microvasculature (Lewis et al., 
2000). 
1.3.2.7 ATP regulation of vascular tone 
ATP may be not only found in sympathetic nerves but also in sensory nerves 
(Burnstock and Ralevic, 1994). In addition to perivascular nerves, ATP can be 
released from other sources including endothelium, blood borne cells (RBC 
and platelets), damaged tissues and smooth muscle cells (Burnstock, 2008, 
Ralevic, 2009). The neuronally released ATP and ATP released from other 
sources are degraded by ectonucleotidases into ADP, AMP and adenosine 
(Todorov et al., 1997, Zimmermann, 2006). Therefore, ATP released from 
different sources can be degraded into ADP and adenosine thus providing a 
source for these active substances that have been shown to be involved in the 
regulation of vascular tone. For example, it has been shown that ADP evoked 
contractions in human internal mammary artery through the activation of 
P2Y12 receptors (Wihlborg et al., 2004). It has also been demonstrated that 
ATP and its degradation product adenosine mediated negative feedback by 
ATP acting on P2Y receptors and adenosine acting on P1 (A1) receptors in 
sympathetic nerves (Boehm and Huck, 1997, Cunha, 2001). Therefore, ATP 
acts directly as a neuronally released neurotransmitter via P2X and some P2Y 
receptors and through its products of degradation (ADP and adenosine) acting 
on different P2Y and P1 receptors, and as an extracellular signalling molecule 
released from endothelium and other tissues can influence different systems 
and organs in the human body (see Fig. 1.2). ATP effects mediated through its 
direct involvement or via its products of breakdown have been shown in recent 
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studies. For example, a role of ATP has been shown in the pathophysiology of 
hypertension (Inscho et al., 2004), pulmonary hypertension, (Sprague et al., 
2003) and atherosclerosis (Burnstock, 2002, Gerasimovskaya et al., 2008). 
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Fig. 1.2 Diagram shows the effects of different purines involved in the control of blood vessels. 
ATP is released as a cotransmitter with noradrenaline (NA) and neuropeptide Y (NPY) from 
sympathetic nerves in the adventitia to act at smooth muscle P2X1 receptors, causing constriction; 
ATP is released with calcitonin gene related peptide (CGRP) and substance P (SP) from sensory-
motor nerves to act on smooth muscle P2Y receptors, causing vasodilatation. P1 (A1) receptors 
RQQHUYHWHUPLQDOVRIV\PSDWKHWLFDQGVHQVRU\QHUYHVPHGLDWHDGHQRVLQH¶VRULJLQDWLQJIURPWKH
breakdown of ATP) modulation of transmitter release. P2X2/3 receptors are present on sensory 
nerve endings. P1 (A2) receptors on vascular smooth muscle mediate vasodilatation. Aggregating 
platelets release ATP to act on endothelial P2Y1 and P2Y2 receptors causing the release of nitric 
oxide (NO) and subsequent vasodilatation. (Adapted from Burnstock 2008). 
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1.3.3 NEUROPEPTIDE Y (NPY) 
Using the technique of high performance liquid chromatography examining 
samples obtained from porcine brain, a new peptide was discovered that was 
called neuropeptide Y (NPY) (Tatemoto et al., 1982a, Tatemoto, 1982b). In 
1983, Lundberg and co-workers used radioimmunoassay and 
immunocytochemistry techniques to show the presence of NPY in high levels 
in peripheral noradrenergic neurons in vas deferens and blood vessels of 
guinea-pig, cat, pig and man (Lundberg et al., 1983). Chemical and surgical 
sympathectomy followed by immunohistochemical investigation have 
demonstrated the coexistence and cooperation of NA and NPY in perivascular 
nerves of many blood vessels in mice, rat, guinea-pig, rabbits and humans 
(Ekblad et al., 1984). Furthermore, in the rat vas deferens NPY and NA have 
been located in large vesicles while the small vesicles contain NA (Fried et al., 
1985a, Fried et al., 1985b). 
The presence of NPY in sympathetic vesicles co-stored with NA poses 
questions about its physiological role in the effector organs supplied by 
sympathetic nerves, such as blood vessels. The exogenous application of NPY 
on isolated segments of basilar, gastro-epiploic, and femoral arteries in the 
rabbit as well as in smooth muscle of cerebral arteries of cats, potentiated the 
vasoconstrictor effect of NA (Edvinsson et al., 1984, Edvinsson, 1985). 
Furthermore, a recent study using the wire myograph coupled with confocal 
microscopy showed that exogenous NPY increased calcium waves frequency 
produced by the noradrenergic agonist phenylephrine in rat mesenteric arteries 
(Wier et al., 2009). Other experiments in the pig hind limb vasculature showed 
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that NPY played an important role as a sympathetic transmitter (Modin et al., 
1993). The use of BIBP-3226, a Y1 receptor selective antagonist, enabled Han 
and co-workers to demonstrate that 30% of the vasoconstriction produced by 
sympathetic nerve stimulation in the rat mesenteric vascular bed was mediated 
by NPY (Han et al., 1998).  
With regard to vascular sympathetic neurotransmission, NPY acts on two NPY 
receptors, NPY1 and NPY2 (Wahlestedt et al., 1990). The NPY1 receptor is 
located mostly postjunctionally on the surface of the vascular smooth muscle. 
It has been suggested that the NPY1 receptor is mainly involved in potentiating 
the NA and ATP-evoked vasomotor responses in different blood vessels such 
as in the rat mesenteric bed (Donoso et al., 1997). The NPY2 receptor is largely 
presynaptic in origin, mainly involved in reducing the release of NA and ATP 
from sympathetic perivascular nerves (see Fig. 1.3) (Pablo Huidobro-Toro and 
Verónica Donoso, 2004). At present there are five subtypes of NPY receptors: 
NPY1, NPY2, NPY4, NPY5 and NPY6 (Alexander, 2009). 
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Figure. 1.3 Diagram shows the release of different neurotransmitters; noradrenaline (NA), ATP 
and neuropeptide Y (NPY) from sympathetic nerve varicosity, and their effect on different 
receptors; D1- and D2- adrenoceptors, Y1 and Y2 and P2X on the postsynaptic membrane. 
(Adapted from Ralevic 2009) 
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1.4 AIMS AND OBJECTIVES 
The relative contribution of ATP as a sympathetic cotransmitter varies 
according to vascular preparation, size of blood vessels and the underlying 
experimental conditions such as vascular tone. Vascular tone is the ability of 
all blood vessels to exhibit a degree of constriction relative to their maximally 
dilated state under basal tone conditions in vivo. It has previously been shown 
that, in rat perfused mesenteric bed, raising vascular tone with U46619 
revealed a functional role for ATP, while increasing intraluminal pressure 
showed a predominant functional role for ATP in pressurised rat mesenteric 
arteries. Thus, the aim was to investigate this in porcine tissue since it is more 
closely related to that of man. 
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2 METHODS 
2.1 PORCINE PERFUSED MESENTERIC ARTERIAL BED 
PREPARATION 
Mesenteries were obtained from male or female large white Danish pigs, aged 
about 10 weeks and about 80 kilograms in weight, after slaughter at a local 
abattoir. The mesenteries (which had been separated from the intestines) were 
immediately transported to the laboratory in containers filled with chilled 
Krebs-Henseleit solution with the following composition (mM): NaCl 128, 
KCl 4.8, NaHCO3 25, MgSO4 1.1, KH2PO4 1.2, CaCl22H2O 1.25 and glucose 
12, that had previously been gassed with 95% O2±5% CO2. The superior 
mesenteric artery was identified and one of the first order branches was 
dissected out together with part of the mesentery containing the whole vascular 
tree (i.e. the first order branch artery and the rest of its vascular tree) (see Fig. 
2.1).  
Tissue was then placed in Krebs solution containing 2% Ficoll and refrigerated 
overnight at 4 °C (preliminary experiments showed that the responses to EFS 
obtained in fresh tissues and in overnight incubated tissues were similar in 
size). The next day fine dissection was used to expose the first order branch 
artery, which was cannulated using a blunted hypodermic needle (No. 21). 
This acted as the site of perfusion and as the positive electrode. The cannulated 
preparation was then placed on a stainless steel grid (which acted as the 
negative electrode) in a humid chamber, in which it was perfused at a flow rate 
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of 5 ml / min using a peristaltic pump (model 755-30, Cole-Parmer, Chicago, 
IL) (see Fig. 2.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
In order to monitor changes in contractility of the mesenteric bed, a pressure 
transducer (model P23XL: Viggo-Spectramed, Oxnard, CA) was used to 
monitor the perfusion pressure (mmHg). Changes were recorded using a 
powerlab (ADInstruments, Pty Ltd., Castle Hill, Australia). The tissue was 
Fig. 2.1 Picture of the whole porcine isolated mesenteric arterial bed shows (1) superior mesenteric 
artery, (2) first order branch artery, (3) second order branch arteries, (4) third order branch artery, (5) 
terminal small arteries, (6) small intestine and (7) part of the tissue covering the mesenteric bed, which 
has been dissected and reflected to expose the underlying vascular tree. 
(1)  
(5)
(2)
(3)
(4)
(6)
(7)
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equilibrated for 60 min before experimentation. A Grass SD9 stimulator was 
used to apply electrical field stimulation (EFS) (2-16 Hz, 1 ms, 90 V, 30 s). 
 
 
 
 
 
 
 
 
2.2 PREPARATION OF PORCINE ISOLATED ARTERIES 
FOR ISOMETRIC RECORDING 
Porcine mesenteries were obtained from a local abattoir and transported to the 
laboratory in Krebs-Henseleit buffer placed on ice. First and third order 
porcine mesenteric arteries were dissected out and placed in Krebs-Henseleit 
buffer with the following composition (mM) NaCl 128, KCl 4.8, NaHCO3 25, 
MgSO4 1.1, KH2PO4 1.2, CaCl22H2O 1.25 and glucose 12, gassed with 95% 
O2±5% CO2 containing 2% Ficoll and stored overnight at 4 ºC. The next day 
mesenteric arteries were dissected into 5 mm segments and suspended between 
two supports, in organ baths containing Krebs-Henseleit buffer maintained at 
37 ºC and constantly gassed with 95% O2±5% CO2. A thin wire (upper 
support) was inserted through the lumen of the arterial ring while a second 
Cannula
Stainless steel wire mesh
Perfusate
Roller pumps
Pressure transducer
Recorder
Perfusate
Electrical 
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Porcine isolated 
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Fig. 2.2 Set up used to perfuse porcine isolated mesenteric arterial bed (see text for details). 
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wire (lower support), attached to an electrode assembly, was also threaded 
through the lumen. The tissue was then suspended between the two supports 
(see Fig. 2.3). The electrode assembly was connected to a Grass SD9 
stimulator, while the upper support was connected by a thread to a force 
transducer (World Precision Instruments, Sarasota, Florida, U.S.A) linked to a 
Maclab data acquisition system (AD Instruments Ltd, Hastings, UK) via an 
amplifier. After a 15 min equilibration period, tension was applied to the first 
order arteries (10 g) and to the third order arteries (4 g). Arteries were allowed 
to relax to a final resting tension of between (2-4 g) for first order arteries and 
(1-2 g) for third order arteries. The tissues were contracted 2 times with KCl 
(60 mM) with a 30 min interval between the contractions. Tissues were then 
washed with Krebs-Henseleit buffer and allowed to equilibrate for 60 min. 
After the equilibration period, responses to EFS (2-32 Hz, 1ms, 90 V, 30 s) 
were determined. The interval between the frequencies was variable (2-5 min), 
and was determined by the return to baseline after each stimulation, with a 
minimum interval of 2 min if there was no response. In other experiments 
responses tRĮȕ-methyleneATP and exogenous NA were determined. 
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2.3 IMMUNOHISTOCHEMICAL STAINING  
2.3.1 Tissue preparation 
Porcine mesenteries were obtained as described in section 2.1. Fine dissection 
was carried out to identify small terminal branch arteries using a dissecting 
microscope (see Fig. 2.1). Arteries were carefully dissected free of excess fat 
and connective tissue and cut into segments approximately 5 mm long. For 
immunohistochemical staining, segments were fixed in 4% paraformaldehyde, 
- +
1
2
3
4
5
6
8
7
 
Fig. 2.3 Diagram showing an isometric set up including (1) transducer, (2) a 
thin thread attached to a thin wire (upper support), (3) organ bath, (4) 
negative electrode, (5) blood vessel mounted between upper and lower 
supports, (6) thin wire (lower support) attached to a tissue holder, (7) positive 
electrode, (8) electrical stimulator. 
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for 2 h. Vessels were then placed in a 24 well plate where 5 ml of phosphate 
buffered saline (PBS) was added onto each specimen for 30 min. Specimens 
were washed in phosphate-buffered saline twice for 5 min, after which they 
were ready for staining. 
2.3.2 Immunohistochemical Staining 
Whole-mount segments of porcine mesenteric arteries were stained using the 
standard indirect immunofluorescence technique. Background staining was 
reduced by incubation in 2% normal goat serum (1 in 10 dilution) for 10 min at 
room temperature, in all preparations. In some preparations primary mouse 
monoclonal antibody to protein gene product 9.5 (PGP9.5) (1 in 10 dilution) 
was applied for 24 h in a humid chamber at room temperature. After washing 
twice for 5 min in 0.2% Tween in phosphate-buffered saline, fluoresceine 
conjugated rabbit anti±mouse IgG secondary antibody (Alexa Fluor 568 bright 
orange-red fluorescent dye) was applied for 2 h in a humid chamber covered 
with foil at room temperature. In other preparations primary rabbit polyclonal 
antibody to tyrosine hydroxylase (TH) (1 in 500 dilution), was applied for 24 h 
in a humid chamber at room temperature. Tissues were washed twice for 5 min 
in 0.2% Tween in phosphate-buffered saline, then fluoresceine conjugated goat 
anti±rabbit IgG secondary antibody (Alexa Fluor 488 bright green fluorescent 
dye) was applied for 2 h in a humid chamber covered with foil at room 
temperature. All preparations were washed a further 2 times for 5 min in 0.2% 
Tween in phosphate-buffered saline, then DAPI (1 in 500 dilution), a 
fluorescent nuclear stain in 0.2% Tween in phosphate-buffered saline was 
added to the samples for 10 min. After a further 2 times washing for 5 min in 
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0.2% Tween in phosphate-buffered saline the samples were mounted on glass 
slides. In parallel, in some arteries, the same protocol was used without the 
addition of primary antibodies as controls. 
Fluorescence was detected using a Leica TCS SP2 confocal laser scanning 
microscope equipped with 405 diode, argon and 561 lasers. DAPI, Alexa 488, 
and Alexa 568 were excited with the 405, 488 and 561 nm lines respectively. 
Each arterial segment was imaged separately, emissions were separated using 
an acousto-optical beam splitter (AOBS), and then merged using the Leica 
confocal software. Whole mount preparations were viewed using a Leica 
DMIRE2 stand and a 20X plan apochromat objective with a 0.7 numerical 
aperture. The images (512 x 512 pixels) were then obtained sequentially from 
two channels using a confocal pinhole of 1. The images were stored as TIFF 
files. Z-stacks were acquired using a 1.5 µm step height. Each frame was 
acquired 3 times and an average presented. 
2.4 PORCINE MESENTERIC SMALL ARTERIES 
PREPARATION 
Porcine mesenteries were obtained as described in section 2.1. Fine dissection 
was carried out to identify the small terminal branch arteries (see Fig. 2.1) 
using a dissecting microscope. Small arteries were carefully dissected free of 
excess fat, connective tissue and separated from the veins and then cut into 
segments approximately 2 µm long. Next, vessels were mounted on fine 
tungsten wires (40 µm diameter), and placed between the plastic jaws of a dual 
channel Mulvany-Halpern wire myograph (Myo-Interface Model 410A, 
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Danish Myo Technology, Denmark) (Mulvany and Halpern, 1977) (see Fig. 
2.4). Vessels were kept at 37°C in Krebs±Henseleit buffer, gassed with 5% 
CO2/95% O2. A tension of 1g was applied (preliminary experiments showed 
that when 1 g tension was applied, a larger response was obtained compared to 
that produced when 0.5 g was applied to the mounted vessels). Vessels were 
left to relax to a resting tension of 0.3- 0.5 g. The viability and contractile 
integrity of each vessel was then tested by its ability to contract to KCl (60 
mM) by at least 0.4 g. Tension was measured and was recorded on a MacLab 
4e recording system (ADInstruments, U.K.). 
The perivascular nerves were activated electrically through two platinum 
electrodes mounted in the plastic jaws, either side of the blood vessel. EFS (2-
16 Hz, 1 ms, 10 V, 30 s) was supplied by a stimulator unit (DS2; Digitimer 
Ltd, Welwyn Garden City, UK). 
 
 
 
 
 
 
A
B
C
D
Fig. 2.4 Diagram showing mounting apparatus of a wire myograph including A) mounting 
plastic jaws, B) mounted blood vessel, C) stimulation electrode and D) fine tungsten wires 
(40 µm diameter). 
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2.5 RAT MESENTERIC ARTERIES PREPARATION 
Male Wistar rats (200±250 g) were stunned by a blow to the cranium and 
killed by exsanguination. The gut with attached mesenteric vascular bed was 
removed through an incision in the abdominal cavity. The mesentery was then 
kept in physiological salt solution containing (mM): NaCl, 118; NaHCO3, 25; 
KCl,4.8; MgSO4, 1.2; KH2PO4, 1.2; glucose, 11.1; CaCl2, 1.25; and gassed 
with 95% O2±5% CO2 (pH 7.4). Thereafter, a first order mesenteric artery was 
identified and followed to the point where it further divided into second-order 
branches and followed until they further divided into third-order branches. 
This part of the vascular tree was isolated, and adherent fat and connective 
tissue were removed from the first and the second order arteries, except at the 
branch point, where it was left intact. The pre-dissected tissue was then 
transferred into a pressure myograph filled with physiological salt solution. 
The pressure myograph contains two electrodes; on one end a glass electrode 
and on the other end a suction electrode. Next, using a dissecting microscope, 
the first order artery was directed towards the suction electrode and sucked into 
it (see Fig. 2.5). Meanwhile the second order artery was directed towards the 
glass electrode and mounted onto it and tied securely using a fine nylon suture. 
Thereafter, physiological salt solution was flushed through the glass electrode 
to remove any remaining blood in the second order artery. Finally the second 
order mesenteric artery was tied off just distal to the branch point and the fat 
left intact at the branch point was then used to create a tight seal at the mouth 
of the suction electrode. The glass cannula, which was filled with 
physiological saline, was then connected to a pressure servo controlled 
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peristaltic pump (Living Systems, Burlington, VT, USA), allowing precise 
control of intraluminal pressure. The tissues were superfused with 
physiological salt solution and maintained at 36±37ƕC. Vessels were 
pressurized to 90 mmHg, and allowed to equilibrate for 20 ± 30 min. 
The perivascular nerves were activated electrically through a stimulating 
electrode that consisted of a polyethylene tube (׽ȝPOXPHQGLDPHWHUZLWK
a silver wire electrode within the lumen and another electrode wrapped around 
the outside. EFS (1 ms, 50 pulses, 10-20 V, 0.5-10 Hz) was supplied by a 
stimulus isolation unit (DS2; Digitimer Ltd, Welwyn Garden City, UK). 
Arteries were visualized using a CCD camera attached to an inverted 
microscope and their inner diameter was continually monitored using an edge 
tracking device (video dimension analyser model V94; Living Systems, 
Burlington, VT, USA). 
 
 
 
 
 
 
 
 
Fig. 2.5 Set up for a pressure myograph showing (A) fat tissue left to form tight seal, (B) suction 
electrode, (C) second order rat mesenteric artery pressurised to 90 mmHg, (D) thread to tie the 
artery and (E) glass cannula connected to a pressure transducer. 
A 
B 
C 
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2.6 PORCINE MESENTERIC ARTERIES PREPARATION 
Porcine mesenteries were obtained as described in section 2.1. Fine dissection 
was carried out to identify the small terminal branch arteries using a dissecting 
microscope. The anatomical pattern of the porcine small blood vessels was 
different from that of the rat. There was no obvious branching pattern although 
there were long segments of small arteries that were companied by a closely 
attached vein. Therefore, these vessels were carefully dissected free of excess 
fat and connective tissue and then separated from the veins as follows. Three 
quarters of the closely attached vein were carefully dissected and removed 
while the remaining piece of the vein and its surrounding connective tissue was 
left (to enable creation of a tight seal in the suction electrode). The pre-
dissected tissue was transferred to the pressure myograph chamber which was 
filled with physiological salt solution. Using a dissecting microscope, the end 
of the artery that was left with the remaining piece of the vein and its 
surrounding connective tissue attached was directed towards the suction 
electrode and sucked into it. Meanwhile the other end of the artery was 
directed towards the glass electrode and mounted onto it, with the electrode in 
the lumen of the vessel, and tied securely using fine nylon suture. Thereafter, 
physiological salt solution was flushed through the glass electrode to remove 
any remaining blood in the artery. Finally the end of the artery that was left 
intact with its surrounding connective tissue and the vein was tied off, and 
sucked into the suction electrode to create a tight seal at the mouth of the 
suction electrode. 
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2.7 DRUGS 
3UD]RVLQĮ,ȕ-methyleneATP, guanethidine, nifedipine, U46619 and capsaicin 
were obtained from Sigma (Poole, Dorset, UK). BIBP3226 and endothelin-1 
(porcine) were obtained from TOCRIS, Bristol USA. RX811059 was from 
Reckit and Colman, Hull, UK. (±) arterenol (noradrenaline hydrochloride) and 
YM-12617 were obtained from Sigma (Poole, Dorset, UK). NF-449 was 
obtained from Calbiochem, Nottingham, UK. U46619 stock concentration was 
10 mg/ml in methyl acetate and reconstituted in ethanol to form a 10-2 M 
solution, while capsaicin and nifedipine were dissolved in ethanol to form a 10-
1
 M solution for capsaicin and 10-3 M for nifedipine. All other drugs were 
dissolved in water. The experiments with NF-449 and nifedipine were 
performed with the light in the laboratory switched off due to the light 
sensitivity of the compound. 
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3 ATP ACTS AS A FUNCTIONAL SYMPATHETIC 
NEUROTRANSMITTER IN THE PORCINE 
PERFUSED MESENTERY AFTER RAISING 
TONE  
3.1 INTRODUCTION 
Prior to 1970 NA was considered to be the sole neurotransmitter released from 
sympathetic perivascular nerves in blood vessels. However, the establishment 
of co-transmission as a concept in autonomic neuroscience (Burnstock, 1976, 
Burnstock, 2004) made it possible for other biological substances to be 
considered as neurotransmitters released with NA from the sympathetic 
perivascular nerves. For example, ATP has now been shown to be released 
from sympathetic nerves as a co-transmitter in a variety of different blood 
vessels, including the rabbit mesenteric artery (Ishikawa, 1985), rabbit hepatic 
artery (Brizzolara and Burnstock, 1990) and human saphenous vein (Racchi et 
al., 1999). 
A number of studies have investigated the importance of ATP as a sympathetic 
neurotransmitter, mainly using isolated arteries, and it has been shown that the 
role for ATP as a sympathetic neurotransmitter is more evident in small 
arteries compared to large (Martin et al., 1991, Gitterman and Evans, 2001). 
Relatively few studies have investigated the role of ATP as a neurotransmitter 
in the whole organ. However, in the rat isolated perfused kidney, stimulation 
of periarterial nerves at lower frequencies produced renal vasoconstriction that 
was mediated by ATP (Schwartz and Malik, 1989). In a different study in the 
3. ATP acts as a functional sympathetic neurotransmitter in the porcine perfused mesentery after raising tone 
51 
 
same bed ATP was shown to act as neuromodulator where, after it was 
released from sympathetic nerves, it inhibited the release of NA, via 
stimulation of prejunctional P2 receptors (Bohmann et al., 1997). In the rat 
isolated mesenteric arterial bed responses to nerve stimulation did not involve 
ATP under normal experimental conditions. However, after raising tone (pre-
constriction of the blood vessels) with vasoconstrictor agents including 
(U46619 a thromboxane A2 agonist) or endothelin-1, ATP was shown to be 
involved as a functional sympathetic neurotransmitter (Pakdeechote et al., 
2007). 
In the present study, I have used the mesenteric arterial bed isolated from pigs 
to investigate the potential involvement of ATP as a sympathetic 
neurotransmitter. The mesenteric vascular bed plays a very important role in 
determining the haemodynamics of the cardiovascular system, with up to 25 % 
of blood flow passing through mesenteric arteries (Takagi et al., 1988) and the 
porcine cardiovascular system is similar in terms of haemodynamics and 
anatomical size to the human cardiovascular system. U46619 was used to 
increase the baseline perfusion pressure. 
3.2 Materials and methods 
3.2.1 Porcine perfused mesenteric arterial bed preparation 
Mesenteries were obtained from male or female large white Danish pigs, after 
slaughter at a local abattoir. The mesenteries were immediately transported to 
3. ATP acts as a functional sympathetic neurotransmitter in the porcine perfused mesentery after raising tone 
52 
 
the laboratory in containers filled with chilled Krebs-Henseleit solution. The 
mesenteric arterial bed was set up as described in section 2.1. 
3.2.2 Responses to EFS in porcine isolated mesenteric arterial bed under 
basal tone conditions 
After an initial 60 min equilibration period, responses to EFS (2-16 Hz, 1 ms, 
90 V, 30 s) were determined. The interval between the frequencies was 
variable (2-10 min), and was determined by the return to baseline after each 
stimulation, with longer intervals at higher frequencies. After a further 30 min, 
a second frequency response curve (FRC) was generated to investigate the 
reproducibility of the FRCs. In some experiments prazosin (0.1 0 DQ Į1-
adrenoceptor antagonist (Cambridge et al., 1977, Pakdeechote et al., 2007), 
was added after the first FRC, while a combination of prazosin (0.1 µM) plus 
guanethidine (1 µM), a sympathetic neurone blocking agent (Williams and 
Clarke, 1995), was added after the second FRC and a third FRC was 
constructed ,Q RWKHU H[SHULPHQWV Įȕ-methyleneATP (1 µM) (Kasakov and 
Burnstock, 1982, Sneddon and Burnstock, 1984, Neild and Kotecha, 1986) 
was added after the first FRC. Įȕ-methyleneATP is a P2X receptor 
desensitizing agent which acts at two different receptors P2X1 and P2X3 
receptors; P2X1 receptors are expressed on the vascular smooth muscle where 
they cause vasoconstriction, while P2X3 receptors are expressed mainly on 
sensory nerves (Ralevic and Burnstock, 1998). All antagonist drugs were left 
for 30 min before testing their effect on the electrically-evoked vasocontractile 
responses. 
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3.2.3 Responses to EFS in porcine isolated mesenteric arterial bed under 
raised tone conditions 
U46619, a thromboxane A2 agonist (10-50 nM), was added to raise the tone in 
each preparation (25 ± 10 mmHg above baseline) (Pakdeechote et al., 2007), 
before generating responses to EFS. In some preparations a FRC was obtained 
under basal tone conditions then U46619 was added to raise the tone and a 
second FRC was conducted. In different preparations, after raising tone, two 
consecutive FRCs were generated, separated by a 30 min interval. These were 
used to investigate the reproducibility of the FRCs. In separate preparations the 
effects of (a) guanethidine (1 µM), (b) prazosin (0.1 µM), (c Įȕ-
methyleneATP (1 µM), and (dĮ,ȕ-methyleneATP (1 µM) plus prazosin (0.1 
µM) were investigated by adding these after the first FRC. In some 
preparations a FRC was generated in the presence of U46619 and the tissue 
was then incubated with capsaicin (1 µM), for 30 min. The tissue was then 
washed with Krebs-Henseleit buffer for 30 min and re-exposed to U46619 
before a second FRC was obtained. All antagonist drugs were left for 30 min 
before testing their effect on the electrically-evoked vasocontractile responses. 
3.3 STATISTICAL ANALYSIS 
Data were expressed as a percentage of the response obtained at 16 Hz of the 
first frequency response curve. Results are expressed as the mean ± S.E.M. 
Statistical comparisons were made by two way analysis of variance (ANOVA) 
with Bonferroni post-hoc test, or 6WXGHQW¶V W-test. A value of P < 0.05 was 
taken to indicate statistical significance. 
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3.4 RESULTS 
3.4.1 5ROH RI Į1-adrenoceptors and P2X receptors in mediating 
electrically-evoked vasocontractile responses in porcine isolated 
mesenteric arterial bed under basal tone conditions  
Under basal tone conditions (baseline pressure 42 ± 4 mmHg, n=14), EFS 
elicited frequency-dependent vasoconstrictor responses in the porcine isolated 
mesenteric arterial bed. These responses were relatively variable in amplitude, 
between preparations. Thus, responses were expressed as a percentage of the 
response to 16 Hz obtained in the first FRC. Under basal tone conditions two 
consecutive FRC were reproducible (n=9) (Fig. 3.1). Prazosin 0DQĮ1-
adrenoceptor antagonist, significantly attenuated the electrically-evoked 
vasocontractile responses (e.g. by 70 ± 8% at 16 Hz, P < 0.001, ANOVA 
followed by Bonferroni post-hoc test) (n=12) (Fig. 3.2). A small residual 
response remained that was not blocked by further addition of guanethidine (1 
µM), a sympathetic neuron blocker, presumably due to direct smooth muscle 
activation. Neither prazosin nor guanethidine altered the basal perfusion 
SUHVVXUH Įȕ-methyleneATP (1 µM), a P2X receptor desensitising agent, 
produced a transient contraction (23 ± 4 mmHg, n=9) and its effect on 
responses was estimated once the perfusion pressure had returned to its 
original level, usually after 5-15 min. Įȕ-methyleneATP had no significant 
effect on the vasoconstrictor responses obtained to EFS in the porcine isolated 
mesenteric arterial bed under basal tone conditions (e.g. the response at 16 Hz 
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was 92 ± 20% of the control) (n=9) (Fig. 3.3A and Fig. 3.3B representative 
trace). 
3.4.2 5ROH RI Į1-adrenoceptors and P2X receptors in mediating 
electrically-evoked vasocontractile responses in porcine mesenteric 
arterial bed under raised tone conditions  
The thromboxane A2 agonist U46619 (10-50 nM) increased the perfusion 
pressure from 42 ± 4 mmHg to 68 ± 7 mmHg (P < 0.05, 6WXGHQW¶VXQSDLUHGW-
test) (n=14), and significantly enhanced the electrically-evoked vasocontractile  
response, particularly at higher frequencies (e.g. the response was increased at 
16 Hz by 236 ± 75% (P < 0.05, ANOVA) (n=8) (Fig. 3.4A and Fig. 3.4B 
representative trace). In the presence of U46619, two consecutive FRCs were 
reproducible (n=5) (Fig. 3.5). Under these conditions guanethidine (1 µM) 
almost abolished the vasoconstrictor responses evoked by EFS (P < 0.001, 
ANOVA followed by Bonferroni post-hoc test) (n=4) (Fig. 3.6A). Prazosin 
(0.1 µM) did not alter the raised perfusion pressure but attenuated the 
electrically-evoked vasocontractile responses at all frequencies reaching 
significance at higher frequencies (e.g. 45 ± 5% inhibition at 16 Hz, P < 0.001, 
ANOVA followed by Bonferroni post-hoc test) (n=12) (Fig. 3.6B) under raised 
tone conditions. The inhibition produced by prazosin in the presence of 
U46619 was much less than the 70% inhibition produced under basal tone 
conditions (see Fig. 3.2 and 3.6B).  
In the presence of U46619, Įȕ-methyleneATP (1 µM) produced a transient 
contraction (114 ± 19 mmHg, n=10). This transient contraction was much 
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larger compared to that under basal tone conditions (P < 0.001, unpaired t-test, 
n=10) (see Fig. 3.3B and Fig. 3.7B). Įȕ-methyleneATP pre-treatment 
attenuated the vasoconstrictor responses obtained after EFS in the porcine 
isolated mesenteric arterial bed under conditions of raised tone at all 
frequencies, reaching statistical significance at 16 Hz (49 ± 9% inhibition, P < 
0.001, ANOVA followed by Bonferroni post-hoc test) (n=5) (Fig. 3.7A and 
Fig. 3.7B representative trace). 
TKHFRPELQDWLRQRIĮȕ-methyleneATP (1 µM) and prazosin (0.1 µM) together 
attenuated the responses at all frequencies of stimulation, reaching statistical 
significance at higher frequencies. TKHFRPELQDWLRQRIĮȕ-methyleneATP and 
prazosin together had more effect than prazosin or Įȕ-methyleneATP had 
when they were added alone especially at higher frequencies (e.g. 85 ± 9% 
inhibition at 8 Hz, P < 0.01, ANOVA followed by Bonferroni post-hoc test) 
(n=5) (Fig. 3.8) compared to the inhibition caused by either prazosin alone or 
by Įȕ-methyleneATP alone at 8 Hz (50% and 25% inhibition) respectively. 
However, tKH FRPELQDWLRQ RI Įȕ-methyleneATP and prazosin together had 
less effect compared to that of guanethidine especially at 16 Hz where 
guanethidine inhibited the response by about 85%. 
3.4.3 Effects of capsaicin on the electrically-evoked vasocontractile 
responses in porcine mesenteric vascular bed under raised tone 
conditions 
In the rat perfused mesenteric vascular bed, pre-treatment with capsaicin (1 
µM), a TRPV1 receptor agonist, enhanced the electrically-evoked 
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vasocontractile responses (Pakdeechote et al., 2007). In the present study we 
investigated the effect of pre-treatment of the porcine arterial bed with 
capsaicin (1 µM) for 30 min. Capsaicin did not alter the basal or raised 
perfusion pressure and had no significant effect on the electrically-evoked 
vasocontractile responses in the porcine isolated mesenteric arterial bed (n=9) 
(Fig.3.9) 
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Fig. 3.1 Reproducibility of vasoconstrictor responses to electrical field stimulation (2-
16 Hz, 1ms, 30s, 90 V). Opened bars show the first frequency response curve (FRC 1) 
while closed bars show second frequency response curve (FRC 2) in the porcine 
isolated mesenteric arterial bed under basal tone conditions. Responses are expressed as 
a % of the control response to 16 Hz in the first frequency response curve (n=9). Data 
are shown as mean ± standard error. 
3. ATP acts as a functional sympathetic neurotransmitter in the porcine perfused mesentery after raising tone 
59 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 4 8 16
0
25
50
75
100
125
Control
Prazosin
Prazosin+guanethidine
*
*
*
*
*
*
*
*
**
*
Frequency (Hz)
%
 
R
es
po
n
se
 
Fig. 3.2 Effects of prazosin (0.1 µM) alone and in combination with guanethidine (1 
µM) (n=12), on vasoconstrictor responses to electrical field stimulation (2-16 Hz, 1 ms, 
90 V, 30 s) in the porcine isolated mesenteric arterial bed under basal tone conditions. 
Responses are expressed as a % of the control response to 16 Hz in the first frequency 
response curve. Data are shown as mean ± standard error. ** P < 0.01 vs. control, *** P 
< 0.001 vs. control (ANOVA followed by Bonferroni post-hoc test). 
3. ATP acts as a functional sympathetic neurotransmitter in the porcine perfused mesentery after raising tone 
60 
 
 
 
 
 
 
 
 
 
 
        B) 
 
 
 
 
 
 
 
2 4 8 16
0
25
50
75
100
125 Control
D ,E -Methylene ATP
A)
Frequency (Hz)
%
 
R
es
po
n
se
 
0
Įȕ-methyleneATP
-
2
-
4
-
8
-
16
-
2
-
4
-
8
-
16 (Hz)
100
Pe
rf
u
sio
n
 
pr
es
su
re
 
(m
m
H
g)
10 min
 
Fig. 3.3 A) Effect RI Įȕ-methyleneATP (1 µM) (n=9) on vasoconstrictor responses to 
electrical field stimulation (2-16 Hz, 1 ms, 90 V, 30 s) in the porcine isolated mesenteric 
arterial bed under basal tone conditions. Responses are expressed as a % of the control 
response to 16 Hz in the first frequency response curve. Data are shown as mean ± standard 
error. B) Representative trace showing the effect RI Įȕ-methyleneATP (1 µM) on 
vasoconstrictor responses to nerve stimulation in the porcine isolated mesenteric arterial bed 
under basal tone conditions. 
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Fig. 3.4 A) Effects of U46619 (n=8), on vasoconstrictor responses to electrical field stimulation 
(2-16 Hz, 1 ms, 90 V, 30 s) in the porcine isolated mesenteric arterial bed. Responses are 
expressed as a % of the control response to 16 Hz in the first frequency response curve. Data are 
shown as mean ± standard error. * P < 0. 05 vs. control (ANOVA followed by Bonferroni post-
hoc test). B) Representative trace showing effects of pre-constriction with U46619, on 
vasoconstrictor responses to nerve stimulation in the porcine isolated mesenteric arterial bed 
under basal and raised tone conditions.  
3. ATP acts as a functional sympathetic neurotransmitter in the porcine perfused mesentery after raising tone 
62 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
2 4 8 16
0
25
50
75
100
125
FRC 1
FRC 2
Frequency (Hz)
%
 
R
es
po
n
se
 
Fig. 3.5 Reproducibility of vasoconstrictor responses to electrical field stimulation (2-16 
Hz, 1 ms, 90 V, 30 s). Open bars show the first frequency response curve (FRC 1) while 
closed bars show second frequency response curve (FRC 2) in the porcine isolated 
mesenteric arterial bed under raised tone conditions. Responses are expressed as a % of the 
control response to 16 Hz in the first frequency response curve (n=5). Data are shown as 
mean ± standard error. 
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Fig. 3.6 Effects of A) guanethidine (1 µM) (n=4), or B) prazosin (0.1 µM) (n=12), on 
vasoconstrictor responses to electrical field stimulation (2-16 Hz, 1 ms, 90 V, 30 s) in the 
porcine isolated mesenteric arterial bed under raised tone conditions. Responses are 
expressed as a % of the control response to 16 Hz in the first frequency response curve. 
Data are shown as mean ± standard error. ** P < 0.01 vs. control, *** P < 0.001 vs. control 
(ANOVA followed by Bonferroni post-hoc test). 
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Fig. 3.7 A) Effects of Įȕ-methyleneATP (1 µM) (n=5), on vasoconstrictor responses to electrical 
field stimulation (2-16 Hz, 1 ms, 90 V, 30 s) in the porcine isolated mesenteric arterial bed under 
raised tone conditions induced by U46619 (10-25 nM). Responses are expressed as a % of the 
control response to 16 Hz in the first frequency response curve. Data are shown as mean ± 
standard error. *** P < 0.001 vs. control (ANOVA followed by Bonferroni post-hoc test). B) 
Representative WUDFHVKRZLQJHIIHFWVRIĮȕ-methyleneATP (1 µM) on vasoconstrictor responses 
to nerve stimulation in the porcine isolated mesenteric arterial bed under raised tone conditions. 
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Fig. 3.8 Effects of SUD]RVLQ0SOXVĮȕ-methyleneATP (1 µM) (n=5) on vasoconstrictor 
responses to electrical field stimulation (2-16 Hz, 1 ms, 90 V, 30 s) in the porcine isolated 
mesenteric arterial bed under raised tone conditions. Responses are expressed as a % of the 
control response to 16 Hz in the first frequency response curve. Data are shown as mean ± 
standard error. ** P < 0.01 vs. control, *** P < 0.001 vs. control (ANOVA followed by 
Bonferroni post-hoc test). 
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Fig. 3.9 Effect of capsaicin (1 µM) (n=9) on vasoconstrictor responses to electrical field 
stimulation (2-16 Hz, 1 ms, 90 V, 30 s) in the porcine isolated mesenteric arterial bed in the 
presence of U46619. Responses are expressed as a % of the control response to 16 Hz in the 
first frequency response curve. Data are shown as mean ± standard error. 
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3.5 DISCUSSION 
The main finding of the present study is that pre-constriction with U46619 
significantly enhanced the electrically-evoked vasoconstrictor responses in the 
porcine isolated mesenteric arterial bed, and this was associated with 
uncovering a role for ATP acting as a sympathetic co-transmitter, which was 
not evident under basal tone conditions. 
Under basal tone conditions, the present results show that vasoconstrictor 
responses to nerve stimulation were sensitive to Į1-adrenoceptor blockade by 
prazosin, but resistant to P2X receptor desensitization with Įȕ-methyleneATP. 
This indicates that the neuronally-evoked vasoconstrictor responses were 
mediated mainly via the stimulation of postjunctional Į1-adrenoceptors. Since 
guanethidine produced a similar sized attenuation of the nerve-mediated 
response to that produced by prazosin, this suggests that NA is the principal 
sympathetic neurotransmitter acting in the porcine isolated mesenteric arterial 
bed under basal tone conditions. There was a response remaining at high 
frequencies that was not blocked by prazosin or guanethidine that, presumably, 
reflects direct activation of the smooth muscle with the stimulation parameters 
used. Since prazosin abolishes response to nerve stimulation in many blood 
vessels from several species such as the isolated perfused mesenteric vascular 
bed of rat (Eikenburg, 1984, Williams and Clarke, 1995), and pig prostatic 
small arteries (Recio et al., 2008), this has led to the widespread view that NA 
is the predominant neurotransmitter in the vasculature. 
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The failure of the 3;UHFHSWRUGHVHQVLWL]LQJDJHQWĮȕ-methyleneATP to alter 
the neuronally-evoked vasoconstrictor responses under basal tone conditions in 
the porcine mesenteric arterial bed indicates that ATP is not involved as a 
functional sympathetic neurotransmitter in this bed. This observation is 
consistent with the results obtained from experiments in the rabbit perfused 
kidney and the rat mesenteric arterial bed under basal tone conditions where 
responses to EFS were blocked by prazosin but not by Įȕ-methyleneATP (von 
Kugelgen and Starke, 1985, Pakdeechote et al., 2007). 
The resistance to Įȕ-methyleneATP under basal tone conditions in the present 
study was perhaps not surprising, since only a few studies have shown a role 
for ATP as a sympathetic neurotransmitter in blood vessels under basal tone. 
The studies include those on rabbit mesenteric arteries (von Kugelgen and 
Starke, 1985) and the rat perfused kidney (Schwartz and Malik, 1989). A 
possible explanation as to why in these studies ATP had an effect as a 
sympathetic neurotransmitter under basal tone conditions is that the 
involvement of ATP as a sympathetic neurotransmitter may differ among 
species and vary between vascular beds. Nevertheless, it is possible that in 
many blood vessels ATP is released from the sympathetic perivascular nerves 
under basal tone conditions but needs certain experimental conditions in order 
for it to be evident, which is consistent with an observation in human 
saphenous vein where ATP had no effect under basal tone conditions, although 
its release from nerves was demonstrated (Rump and von Kugelgen, 1994). 
Although a purinergic component was not observed at basal tone conditions in 
both porcine and rat mesenteric arterial beds (present study and Pakdeechote et 
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al., 2007), the absence of a purinergic component at basal tone does not appear 
to be characteristic of mesenteric arteries since in the rabbit mesenteric artery 
ATP is the principal transmitter (Ramme et al., 1987). 
Pre-constriction with the thromboxane A2 agonist, U46619, significantly 
increased the perfusion pressure and the size of vasoconstrictor responses to 
electrically-evoked nerve stimulation in the porcine isolated mesenteric arterial 
bed. This is in line with data obtained using the rat perfused mesenteric 
vascular bed (Pakdeechote et al., 2007), as well as in rabbit isolated portal vein 
(Stein and Trachte, 1989), rabbit isolated mesenteric artery (Trachte and Stein, 
1989), and in the human saphenous vein, where U46619 enhanced 
vasoconstrictor responses to both EFS and exogenously applied NA (Vila et 
al., 2001). The present study is in line with these studies in suggesting a 
postjunctional mechanism by which U46619 enhanced the responses, since 
8 DOVR HQKDQFHG WKH UHVSRQVHV WR H[RJHQRXVO\ DSSOLHG Įȕ-
methyleneATP in the porcine isolated mesenteric arterial bed. However 
because neurotransmitter release was not measured in this study, a presynaptic 
mechanism for U46619 cannot be excluded, although in the human saphenous 
vein U46619 did not alter electrically-evoked (3H)-NA release unless it was 
used at concentrations higher than 1 µmol/ l (Molderings et al., 1994). In 
addition, the concentration-response curve to U46619 was not affected by 
prazosin in human saphenous vein suggesting that the action of U46619 does 
not involve release of NA (Vila et al., 2001). 
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After raising tone with U46619, prazosin attenuated the electrically-evoked 
vasocontractile responses, but was less effective than under basal tone 
conditions, particularly at higher frequencies. Thus there was a substantial 
prazosin-resistant response under raised tone conditions. Under raised tone 
conditions Įȕ-methyleneATP significantly blocked the response at higher 
frequencies, indicating that purinergic P2X receptors are involved in mediating 
part of the response. A clear involvement of ATP as a sympathetic co-
transmitter has also been demonstrated in the rat mesenteric vascular bed after 
raising tone using endothelin or U46619 (Pakdeechote et al., 2007). It is 
unlikely that the contraction caused by Įȕ-methyleneATP have altered all 
contractions in general since electrically evoked responses were not altered by 
the addition of Įȕ-methyleneATP under basal tone conditions. 
While it is possible that U46619 may increase the release of ATP from 
sympathetic nerves, a more likely explanation is a postjunctional mechanism. 
U46619 enhanced responses to the application of exogenous Įȕ-
methyleneATP, showing the smooth muscle is more responsive to P2X 
receptor activation under these conditions. One possibility is that U46619 
makes the membrane potential more positive such that there is an increase in 
the ATP-mediated opening of L-type Ca2+ cannels leading to contraction. With 
a more negative membrane potential (in the absence of U46619), ATP via P2X 
receptors may not cause a sufficient depolarization to the open probability of 
these channels to promote a vasoconstriction. A similar process has been 
described in rat mesenteric arteries held under pressure; raising pressure from 
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30 to 90 mmHg resulted in depolarization and increased the function of ATP 
as a neurotransmitter (Rummery et al., 2007). 
Under raised tone conditions the combination of SUD]RVLQ DQG Įȕ-
methyleneATP inhibited electrically-evoked responses at all frequencies but to 
a smaller extent than the sympathetic neuron blocker guanethidine, which 
essentially abolished the vasoconstrictor responses to EFS under these 
conditions. This raises possibility of the involvement of other 
neurotransmitters in mediating the vasoconstrictor response in the porcine 
arterial bed at raised tone. Neuropeptide Y (NPY) is a possible candidate. 
Although NPY is generally regarded as a neuromodulator, it has been shown to 
have a direct vasoconstrictor effect following release as a sympathetic co-
transmitter in rat mesenteric arteries (Chu and Beilin, 1998, Han et al., 1998), 
and in human cerebral arteries (Edvinsson et al., 1994). Clearly the 
involvement of NPY as a sympathetic co-transmitter needs to be investigated 
further in the porcine isolated mesenteric arterial bed. 
It has been shown that EFS of capsaicin-sensitive sensory nerves elicited 
vasorelaxation mediated by calcitonin gene-related peptide (CGRP) in the rat 
isolated mesenteric vascular bed (Kawasaki et al., 1988, Rubino et al., 1992). 
Furthermore it has been shown that depletion of capsaicin-sensitive sensory 
afferent nerves of their neurotransmitters by capsaicin enhanced the 
vasocontractile response to EFS in the rat isolated mesenteric vascular bed 
(Pakdeechote et al., 2007). However, in the present study, pre-treatment with 
capsaicin did not alter electrically-evoked vasocontractile responses in the 
3. ATP acts as a functional sympathetic neurotransmitter in the porcine perfused mesentery after raising tone 
72 
 
porcine isolated mesenteric arterial bed. This suggests that sensory nerves do 
not play a significant role in this preparation. 
In conclusion the present study has shown that, at basal tone, NA appears to be 
the only functional (contractile) sympathetic neurotransmitter. In contrast, at 
raised tone there is an additional involvement of ATP as a sympathetic co-
transmitter with NA. Raising the tone with U46619 also revealed the 
possibility that another neurotransmitter, in addition to NA and ATP, might be 
involved in mediating vascular smooth muscle sympathetic neurogenic 
contraction. 
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4 SYMPATHETIC NEUROTRANSMISSION IN 
PORCINE ISOLATED ARTERIES 
4.1 INTRODUCTION 
It is well established that sympathetic perivascular nerves co-store and co-
release not only NA but also ATP, and NPY (Lundberg et al., 1983, Ekblad et 
al., 1984, Burnstock, 1988). There is, however, considerable variation in their 
relative proportion between vessels and species. In most blood vessels NA is 
the main neurotransmitter actiQJ WKURXJK SRVWMXQFWLRQDO Į1-adrenoceptors 
(Angus et al., 1988) DQGRFFDVLRQDOO\Į2-adrenoceptors (Flavahan et al., 1987, 
Dunn et al., 1989), while NPY and ATP are co-transmitters. NPY acts mainly 
through Y1 receptors as a neuromodulator, with some evidence of a direct 
postjunctional effect in some preparations. For example, 30% of the 
vasoconstrictor response produced by sympathetic nerve stimulation in the rat 
mesenteric vascular bed was mediated by NPY (Han et al., 1998). Nevertheless 
there is a consensus that NPY has a more important role as a neuromodulator 
in sympathetic vascular reflexes, potentiating the vasoconstrictor effects of 
NA, for example, in rabbit femoral arteries and cerebral arteries of cat 
(Edvinsson et al., 1984, Edvinsson, 1985), or facilitating the effect of ATP, for 
example, in human saphenous vein (Donoso et al., 2004). ATP mediates its 
effects through P2X (ion channel) and P2Y (G protein-coupled) receptors 
(Erlinge and Burnstock, 2008). P2X1 receptors are most widely distributed in 
vascular smooth muscle and mediate the effects of ATP as a sympathetic co-
transmitter (Lewis and Evans, 2000, Wang et al., 2002). The importance and 
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the degree of involvement of ATP in sympathetic neurotransmission varies, 
depending on species, vascular bed, size of blood vessel and experimental 
conditions. For example, it has been demonstrated that the role of ATP as a 
sympathetic neurotransmitter increases as the size of the blood vessel 
decreases (Gitterman and Evans, 2001). Indeed, in the submucosal arterioles of 
the guinea-pig, ATP was the sole sympathetic neurotransmitter mediating 
contractile responses to sympathetic stimulation, with NA acting as a 
neuromodulator (Evans and Surprenant, 1992). Another important factor which 
has an effect on the relative contribution of ATP as a sympathetic 
neurotransmitter is the experimental conditions used. For example, raising the 
pressure from 30 to 90 mmHg revealed that, at the higher pressure, ATP was 
the predominant sympathetic neurotransmitter  in rat pressurised mesenteric 
arteries (Rummery et al., 2007). Another study has shown that raising the tone 
with U46619, a thromboxane A2 agonist, revealed a functional role for ATP as 
a sympathetic co-transmitter in the rat perfused mesenteric vascular bed, where 
no significant role was observed at basal tone conditions (Pakdeechote et al., 
2007). 
In chapter 3 I showed that ATP was involved in the mediation of electrically-
evoked contractions in the porcine isolated mesenteric arterial bed but only 
under raised tone conditions. Therefore, in the present study, the aim was, to 
investigate the role of ATP in different sized vessels from this vascular tree, 
specifically first and third order arteries. The possible involvement of other 
neurotransmitters in the mediation of electrically-evoked contractile responses 
under basal and raised tone conditions, and the involvement of postjunctional 
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mechanism in the enhanced responses in the presence of raised tone conditions 
were also investigated. 
4.2 MATERIALS AND METHODS 
4.2.1 Tissue preparation 
Porcine mesenteries were obtained from a local abattoir and transported to the 
laboratory in buffer placed on ice. First and third order porcine mesenteric 
arteries were set up for isometric recording as described in section 2.2. 
4.2.2 Characterization of electrically-evoked contractile responses in 
porcine mesenteric first order arteries under basal tone conditions 
Under basal tone conditions, two frequency response curves (FRCs) were 
generated separated by a 30 min interval. These experiments were used as time 
controls. In all experiments a FRC was generated and acted as an internal 
control after which the tissue was exposed to either tetrodotoxin (TTX) (1 
ȝ0, a sodium channel blocker (Lombard et al., 1982), the sympathetic 
neurone blocker guanethidine (1 ȝ0, prazosin (0.1 ȝ0, DQĮ1-adrenoceptor 
antagonist, RX 811059 (1 ȝ0, DQ Į2-adrenoceptor antagonist (Berridge and 
Roach, 1986), Įȕ-methyleneATP (1 ȝ0, a P2X receptor desensitising agent, 
or capsaicin (1 µM), a TRPV1 receptor agonist (Caterina and Julius, 2001) to 
investigate their effects on the contractile response obtained to EFS (2-32 Hz, 
1 ms, 90 V, 30 s). All antagonists were incubated for 30 min before testing 
their effects on the electrically-evoked contractile responses. 
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4.2.3 Effects of capsaicin treatment on electrically-evoked contractile 
responses in porcine mesenteric first order arteries under basal 
tone conditions 
After generating a FRC, capsaicin (1 ȝ0, for 30 min) was used to deplete the 
sensory nerves of their neurotransmitters. The tissue was then washed with 
Krebs-Henseleit buffer for 30 min, and a second FRC was obtained. In other 
experiments the same protocol was adopted, but ethanol (0.1%) was used as a 
vehicle control. 
4.2.4 Characterization of electrically-evoked contractile responses in 
porcine mesenteric first order arteries under raised tone conditions 
In each experiment, prior to exposing the tissue to EFS, U46619 (5-25 nM), a 
thromboxane A2 agonist, was used to raise the tone to about 25% of the level 
of the contraction obtained during the second KCl response, since preliminary 
experiments showed that preconstriction to more than 40% may lead to 
limitation of the smooth muscle ability to further contract. In some 
preparations a FRC was obtained under basal tone conditions before U46619 
was added to raise the tone and a second FRC was conducted under raised tone 
conditions. In other preparations, after raising the tone, three FRCs were 
generated without the addition of antagonists; these were used as time controls. 
In related experiments, after raising the tone, a FRC was generated and acted 
as an internal control and the raised tone was maintained at the same level by 
the further addition of U46619, if required. After generating the first FRC, 
vessels were exposed to either guanethidine (1 ȝ0 SUD]RVLQ  ȝ0, RX 
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811059 (1 ȝ0Įȕ-methyleneATP (1 ȝ0or BIBP3226 (1 ȝ0) (Rudolf et 
al., 1994). In other experiments the tissue was exposed to the sequential effects 
of prazosin (0.1 ȝ0 followed by the combination of prazosin (0.1 ȝ0 plus 
HLWKHU Įȕ-methyleneATP (1 ȝ0, RX 811059 (1 ȝ0 or BIBP3226 (1 ȝ0). 
Alternatively, vessels were exposed to RX 811059 (1 ȝ0 followed by the 
combination of RX 811059 (1 ȝ0 plus Įȕ-methyleneATP (1 ȝ0. All 
antagonists were incubated for 30 min before electrically-evoked contractile 
responses were obtained. 
4.2.5 Characterization of electrically-evoked contractile responses in 
porcine mesenteric third order arteries under basal tone conditions 
Three frequency response curves were generated, with a 30 min interval 
between them, in the absence of antagonist, as controls. In each experiment, a 
FRC was produced and acted as an internal control after which the tissue was 
exposed to the sequential effects of prazosin (0.1 ȝ0 followed by prazosin 
(0.1 ȝ0 plus guanethidine (1 ȝ0RUĮȕ-methyleneATP (1 ȝ0 alone. All 
antagonists were incubated for 30 min before testing their effects on the 
electrically-evoked contractile responses. 
4.2.6 Characterization of electrically-evoked contractile responses in 
porcine mesenteric third order arteries under raised tone 
conditions 
In each experiment prior to exposing the tissue to EFS, U46619 (5-10 nM) was 
used to raise the tone to a level of about 25% of the contraction in response to 
the second KCl response. In some preparations a FRC was obtained under 
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basal tone conditions then U46619 was added to raise the tone and a second 
FRC was conducted. In all other experiments, after raising tone, a FRC was 
generated and acted as an internal control after which the tissue was exposed to 
the sequential application of prazosin (0.1 ȝ0 followed either by the 
combination of prazosin (0.1 ȝ0 plus guanethidine (1 ȝ0, or prazosin (0.1 
ȝ0 SOXV Įȕ-methyleneATP (1 ȝ0, to investigate their effect on the 
contractile response obtained to EFS (2-32 Hz, 1 ms, 90 V, 30 s). The raised 
tone was maintained at the same level by the addition of U46619 if required 
between FRCs. All antagonists were incubated for 30 min before testing their 
effects on the electrically-evoked contractile responses. 
4.2.7 Responses to Įȕ-methyleneATP in porcine mesenteric first order 
arteries under basal tone conditions 
After a 60 min equilibration period, responses to a single application of Įȕ-
methyleneATP (1 µM) under basal tone conditions were conducted. The tissue 
was then washed twice with Krebs-Henseleit buffer for 15 min before a second 
application of Įȕ-methyleneATP (1 µM). In some experiments tissues were 
exposed to the L-type calcium-sensitive channel nifedipine (1 µM) (Surprenant 
et al., 1983) for 30 min before the second response to Įȕ-methyleneATP (1 
µM). 
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4.2.8 5HVSRQVHV WR Įȕ-methyleneATP in porcine mesenteric first order 
arteries under raised tone conditions 
Responses to a single application of Įȕ-methyleneATP (1 µM) were obtained 
under basal tone conditions. The tissue was then washed twice with Krebs-
Henseleit buffer. After 30 min U46619, a thromboxane A2 agonist (5-25 nM) 
was then added to pre-constrict the vessel to about 25% of the second KCl 
response. When a stable contraction to U46619 was achieved, a second 
response to Įȕ-methyleneATP (1 µM) was obtained. In separate experiments 
the same protocol was conducted but endothelin-1 (1-2 nM), a vasoconstrictor 
agent was used instead. 
In some experiments, before exposing the tissue to a second application of Įȕ-
methyleneATP (1 µM), nifedipine (1 µM) was applied for 30 min beforehand. 
In experiments where nifedipine was used, the vessels were pre-constricted to 
35%-45% of the second KCl response. Thus when nifedipine was added in 
these vessels decreased back to 25% of the second KCl response. Only after 
reaching a stable level of pre-constriction was a second response to Įȕ-
methyleneATP (1 µM) obtained.  
4.2.9 Responses to exogenous noradrenaline in porcine mesenteric first 
order arteries under basal and raised tone conditions 
Preliminary experiments showed an element of desensitization when 
concentration response curves were obtained to exogenous NA. Thus to try to 
avoid desensitization, a single application of NA (1 µM or 0.3 µM) was used. 
In some experiments responses to NA (1 µM or 0.3 µM) were obtained under 
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basal tone conditions. The tissue was washed twice with Krebs-Henseleit 
buffer for 30 min and U46619 (5-25) nM was then added to pre-constrict the 
vessel to about 25% of the second KCl response. When a stable contraction to 
U46619 was achieved, a second response to NA (1 µM or 0.3 µM) was 
obtained. 
4.3 STATISTICAL ANALYSIS 
Results are expressed as the mean ± S.E.M. Statistical comparisons were made 
by two way analysis of variance (ANOVA) with Bonferroni post-hoc test or 
6WXGHQW¶V paired or unpaired t-test if the data were normally distributed 
(checked by Shapiro-Wilk normality test) while Mann-Whitney test was used 
if the data were not normally distributed. A value of P < 0.05 was taken to 
indicate statistical significance. 
4.4 RESULTS 
4.4.1 Effects of prazosin, Įȕ-methyleneATP and RX811059 on responses 
to EFS in porcine mesenteric first order arteries under basal tone 
conditions 
Under basal tone conditions EFS produced contractile responses which were 
frequency-dependent, and reproducible (n=5) (Fig. 4.1). Tetrodotoxin (TTX) 
(1 µM), a sodium channel blocker, almost completely abolished the response 
to EFS (P < 0.001, ANOVA followed by Bonferroni post-hoc test) (n=5) (Fig. 
4.2A). Similarly guanethidine (1 µM), a sympathetic neuron blocker, almost 
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abolished the contractile responses to EFS (P < 0.001, ANOVA followed by 
Bonferroni post-hoc test) (n=10) (Fig. 4.2B). 
Prazosin (0.1 µM), an Į1-adrenoceptor antagonist, significantly inhibited the 
contractile responses to EFS (P < 0.001, ANOVA followed by Bonferroni 
post-hoc test) (n=5) (Fig. 4.3A) to a similar extent to that produced by TTX or 
guanethidine (see Fig. 4.2A and B). Įȕ-methyleneATP (1 µM), a P2X 
receptor desensitizing agent, caused a transient contraction (1.7 ± 0.1 g, n=8) 
which returned to the baseline before the construction of the next FRC, but had 
no significant effect on the contractile responses to EFS in porcine mesenteric 
first order arteries (n=8) (Fig. 4.3B). 
:KHQ DVVHVVHG XVLQJ $129$ 5; DQ Į2-adrenoceptor antagonist (1 
ȝ0 ZDV VKRZQ WR VLJQLILFDQWO\ DWWHQXDWH WKH FRQWUDFWLOH UHVSRQVHV WR ()6
(Fig. 4.3C). Although the two FRCs were significantly different (P < 0.05, 
ANOVA) (n=7) there was no significant change at any single frequency upon 
post-hoc analysis. The effect of RX811059 seemed greater at lower 
frequencies than at higher frequencies. 
4.4.2 Effect of capsaicin on electrically-evoked contractile responses in 
porcine mesenteric first order arteries under basal tone conditions 
Capsaicin (1 µM), a TRPV1 receptor agonist, significantly increased the 
electrically-evoked contractile responses (P < 0.001, ANOVA followed by 
Bonferroni post-hoc test) (n=10) (Fig. 4.4A). Similarly ethanol increased the 
electrically-evoked contractile response (P < 0.05, ANOVA followed by 
Bonferroni post-hoc test) (n=8) (Fig. 4.4B) although none of the individual 
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frequencies were statistically significantly different. Capsaicin and ethanol 
both increased responses to EFS. However, the effect of ethanol was just as 
large as that of capsaicin. 
4.4.3 (IIHFWV RI SUD]RVLQ Įȕ-methyleneATP, RX811059 and BIBP3226 
on responses to EFS in porcine mesenteric first order arteries 
under raised tone conditions 
U46619 (5-25 nM) contracted the first order mesenteric arteries by 20 ± 4% of 
the KCl response (n=14). Under raised tone conditions, EFS produced 
contractile responses which were frequency-dependent and slightly larger than 
under basal tone conditions (P < 0.05, ANOVA followed by Bonferroni post-
hoc test) (n=14) (Fig. 4.5). Under raised tone conditions three consecutive 
FRCs were reproducible (n=5) (Fig. 4.6). 
Guanethidine (1 µM), almost abolished the contractile responses to EFS (P < 
0.001, ANOVA followed by Bonferroni post-hoc test) (n=4) (Fig. 4.7A). 
Prazosin (0.1 µM), significantly inhibited the contractile responses to EFS (P < 
0.001, ANOVA followed by Bonferroni post-hoc test) (n=12) (Fig. 4.7B) but 
there was a substantial prazosin-resistant component under raised tone 
conditions.  
Įȕ-methyleneATP (1 µM), a P2X receptor desensitizing agent, caused a 
transient contraction (4.6 ± 0.6 g, n=12), which returned to the same level of 
tone before the construction of the next FRC. When assessed using ANOVA, 
Įȕ-methyleneATP was shown to significantly attenuate the contractile 
responses to EFS. Although the two FRCs were significantly different (P < 
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0.05, ANOVA) (n=12) (Fig. 4.7C) there was no significant change at any 
single frequency upon post-KRFDQDO\VLV7KHDGGLWLRQRIĮȕ-methyleneATP (1 
µM) after prazosin further inhibited the residual pressor response at all 
frequencies reaching significance at 32 Hz (P < 0.05, ANOVA followed by 
Bonferroni post-hoc test) (n=10) (Fig. 4.$7KXVWKHFRPELQHGHIIHFWRIĮȕ-
methyleneATP and prazosin was more evident than that produced by prazosin 
alone.  
RX811059 (1 µM), an Į2-adrenoceptor antagonist, significantly attenuated the 
contractile responses to EFS. Although the two FRCs were significantly 
different there was no significant difference at any individual frequency (P < 
0.05, ANOVA followed by Bonferroni post-hoc test) (n=12) (Fig. 4.8A). 
These results are similar to those produced by RX811059 under basal tone 
conditions (see Fig. 4.3C). Further addition of RX811059 after prazosin 
produced a trend of a further inhibitory effect but this was not significant (n=4) 
(Fig. 4.9B). 
The addition of Įȕ-methyleneATP (1 µM) after RX811059 (1 µM) inhibited 
the residual response left after RX811059 showing that the combined effect of 
Įȕ-methyleneATP and RX811059 had more inhibitory effect than that 
produced by the addition of either of the drugs alone on the electrically-evoked 
contractile responses in porcine mesenteric first order arteries under raised tone 
conditions (P < 0.05, ANOVA followed by Bonferroni post-hoc test) (n=7) 
(Fig. 4.10). 
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BIBP3226 (1 µM), an neuropeptide Y1 receptor antagonist, alone had no 
significant effect on the electrically-evoked contractile responses at raised tone 
(n=5) (Fig. 4.8B). The addition of BIBP3226 (1 µM) after prazosin had no 
significant effect on the electrically-evoked contractile responses in porcine 
mesenteric first order arteries (n=7) (Fig. 4.9C). 
4.4.4 (IIHFWVRISUD]RVLQDQGĮȕ-methyleneATP on responses to EFS in 
porcine mesenteric third order arteries under basal tone conditions 
In porcine mesenteric third order arteries, under basal tone conditions EFS 
produced contractile responses which were frequency-dependent although 
large responses were only seen at high frequencies. Under these conditions 
three consecutive FRCs were reproducible (n=5) (Fig. 4.11). Prazosin (0.1 
µM) significantly inhibited the contractile responses to EFS at basal tone (P < 
0.001, ANOVA followed by Bonferroni post-hoc test) (n=6) (Fig. 4.12A). 
Further addition of guanethidine (1 µM) reduced the residual response after 
prazosin but this further reduction was not significantly different from that 
produced by prazosin alone (n=6) (Fig. 4.12A). 
Įȕ-methyleneATP (1 µM) caused a transient contraction (0.8 ± 0.2 g, n=8) 
which returned to baseline before the construction of the next FRC, and did not 
alter the contractile responses under basal tone conditions (Fig. 4.12B) (n=6).  
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4.4.5 (IIHFWVRISUD]RVLQDQGĮȕ-methyleneATP on responses to EFS in 
porcine third order mesenteric arteries under raised tone 
conditions 
U46619 (5-10 nM), contracted the third order arteries by 20 ± 4% of KCl 
response (n=14). Under these conditions EFS produced contractile responses 
which were frequency-dependent and were modestly larger than under basal 
tone conditions particularly at lower frequencies. Although the two FRCs were 
significantly different none of the responses individual frequencies were 
significantly different upon post-hoc analysis (P < 0.05, ANOVA followed by 
Bonferroni post-hoc test) (n=5) (Fig. 4.13). 
Prazosin (0.1 µM) significantly inhibited the contractile responses to EFS 
under raised tone conditions (P < 0.001, ANOVA followed by Bonferroni 
post-hoc test) (n=6) (Fig. 4.14A). Subsequent addition of guanethidine (1 µM) 
reduced the residual response further, at both 16 and 32 Hz (P < 0.05, ANOVA 
followed by Bonferroni post-hoc test) (n=6) (Fig. 4.14A). 
Įȕ-methyleneATP (1 µM) caused a transient contraction (1.8 ± 0.2 g, n=9) 
which returned to the baseline before beginning the next FRC. This contraction 
was significantly larger than that produced by Įȕ-methyleneATP (1 µM) 
XQGHU EDVDO FRQGLWLRQV 3   6WXGHQW¶V unpaired t-test, n=7). Įȕ-
methyleneATP attenuated the contractile response to EFS, at all frequencies, 
reaching statistical significance at 32 Hz (P < 0.05, ANOVA followed by 
Bonferroni post-hoc test) (n=7) (Fig. 4.14B) in porcine mesenteric  third order 
arteries under raised tone conditions. 
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4.4.6 (IIHFWV RI QLIHGLSLQH RQ UHVSRQVHV WR Įȕ-methyleneATP under 
basal conditions in porcine first order mesenteric arteries 
Under conditions of basal tone Įȕ-methyleneATP (1 µM), produced a 
contractile response that was larger upon the second exposure (P < 0.05, 
6WXGHQW¶VSDLUHG t-test) (n=8) (Fig. 4.15). Nifedipine (1 µM) had no significant 
effect on the response to Įȕ-methyleneATP (1 µM), (n=8) (Fig. 4.16A and B 
representative trace). 
4.4.7 Effects of nifedipine on responsHV WR Įȕ-methyleneATP under 
raised tone conditions in porcine mesenteric first order arteries  
In the presence of U46619 (5-25 nM), the response to Įȕ-methyleneATP (1 
µM) was significantly enhanced (P < 0.001, 6WXGHQW¶VSDLUHG t-test) (n=8) (Fig. 
4.17A and B representative trace). In the presence of U46619, nifedipine (1 
µM) attenuated the response to Įȕ-methyleneATP (1 µM) (P < 0.01, 6WXGHQW¶V
unpaired t-test) (n=8) (Fig. 4.18). 
4.4.8 Effects endothelin-1 RQUHVSRQVHVWRĮȕ-methyleneATP in porcine 
mesenteric arteries  
In the rat perfused mesenteric vascular bed, pre-treatment with endothelin-1, a 
vasoconstrictor agent, enhanced electrically-evoked vasoconstrictor responses 
(Pakdeechote et al., 2007). In the present study we investigated the effect of 
endothelin-1 on responses to Įȕ-methyleneATP (1 µM) in the porcine 
mesenteric arteries.. Endothelin-1 (1-2 nM) contracted porcine mesenteric 
arteries and significantly enhanced the response to Įȕ-methyleneATP (1 µM) 
(P < 0.05, 6WXGHQW¶VSDLUHG t-test) (n=9) (Fig. 4.19).  
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4.4.9 Effects of U46619 on exogenous NA in porcine first order 
mesenteric arteries 
NA (1 µM) produced a contractile response which was enhanced in the 
presence of U46619 (P < 0.016WXGHQW¶VSDLUHGW-test) (n=8) (Fig. 4.20A and B 
representative trace). However, the enhancement produced by NA (1 µM), was 
modest thus, a lower concentration of NA (0.3 µM) was used to avoid any 
underestimation of a possible enhancement that may occur when a higher 
concentration is used. NA (0.3 µM) produced a contractile response which was 
enhanced in the presence of U46619 (P < 0.016WXGHQW¶VSDLUHG W-test) (n=8) 
(Fig. 4.21A and B representative trace). 
4.4.10 &RPSDULVRQ EHWZHHQ WKH HIIHFWV RI Įȕ-methyleneATP on 
electrically-evoked contractile responses in porcine mesenteric first 
and third order arteries 
Įȕ-methyleneATP (1 µM), inhibited the electrically-evoked contractile 
responses in both first and third order arteries at 32 Hz under raised tone 
conditions. It seems that the percentage of inhibition produced by Įȕ-
methyleneATP (1 µM) greater in third order arteries than that produced in first 
order arteries. However that was statistically not significantly (n=9) (Fig. 
4.22). 
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Fig. 4.1 Reproducibility of contractile responses to electrical field stimulation (2-32 Hz, 1ms, 
30s, 90 V). Open bars show the first frequency response curve (FRC 1) while closed bars 
show second frequency response curve (FRC 2) (n=5) in porcine mesenteric first order 
arteries under basal tone conditions. Each bar represents mean ± standard error. 
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Fig. 4.2 Effects of A) tetrodotoxin (TTX, 1 ȝ0Q  or B) guanethidine ȝ0 (n=10) 
on contractile responses to electrical field stimulation (2-32 Hz, 1 ms, 30s, 90 V) in 
porcine mesenteric first order arteries under basal tone conditions. Each bar represents 
mean ± standard error. ** P < 0.01, *** P < 0.001 vs. control (ANOVA followed by 
Bonferroni post-hoc test). 
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Fig. 4.3 Effects of A) prazosin (0.1 ȝ0Q %Įȕ-methyleneATP ȝ0 (n=8), or C) 
RX811059 (1 µM) (n=7) on contractile responses to electrical field stimulation (2-32 Hz, 
1 ms, 30s, 90 V) in porcine mesenteric first order arteries under basal tone conditions. 
Each bar represents mean ± standard error. *** P < 0.001 vs. control. + shows a 
significant difference between curves (P < 0.05, ANOVA followed by Bonferroni post-
hoc test). 
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Fig. 4.4 Effects of A) capsaicin  ȝ0 (n=10), or B) ethanol (0.1%) (n=8), on contractile 
responses to electrical field stimulation (2-32 Hz, 1 ms, 30s, 90 V) in porcine mesenteric first 
order arteries under basal tone conditions. Each bar represents mean ± standard error. * P < 
0.05, ** P < 0.01 vs. control. + shows a significant difference between curves (P < 0.05, ANOV 
followed by Bonferroni post-hoc test). 
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Fig. 4.5 Contractile responses to electrical field stimulation (2-32 Hz, 1 ms, 30s, 90 V) under 
basal tone conditions (control), and in the presence of U46619 (n=14) in porcine mesenteric 
first order arteries. Each bar represents mean ± standard error. + shows a significant 
difference between curves (P < 0.05, ANOV followed by Bonferroni post-hoc test). 
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Fig. 4.6 Reproducibility of contractile responses to electrical field stimulation (2-32 Hz, 
1ms, 30s, 90 V). Open bars show the first frequency response curve (FRC 1), while closed 
bars show the second frequency response curve (FRC 2) and striped bars show the third 
frequency response curve (FRC 3) (n=5) in porcine mesenteric first order arteries under 
raised tone conditions. Each bar represents mean ± standard error. 
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Fig. 4.7 Effects of A) guanethidine ȝ0 (n=4), B) prazosin (0.1 ȝ0Q 2), or CĮȕ-
methyleneATP ȝ0 (n=12), on contractile responses to electrical field stimulation (2-32 
Hz, 1ms, 30s, 90 V) in porcine mesenteric first order arteries under raised tone conditions. 
Each bar represents mean ± standard error. ** P < 0.01, *** P < 0.001 vs. control. + shows 
a significant difference between curves (P < 0.05, ANOVA followed by Bonferroni post-
hoc test). 
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Fig. 4.8 Effects of A) RX811059 (1 µM) (n=12), or B) BIBP3226  ȝ0 (n=5), on 
contractile responses to electrical field stimulation (2-32 Hz, 1ms, 30s, 90 V) in porcine 
mesenteric first order arteries under raised tone conditions. Each bar represents mean ± 
standard error. + shows a significant difference between curves (P < 0.05, ANOVA 
followed by Bonferroni post-hoc test) 
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Fig. 4.9 Effects of A) the sequential addition of prazosin (0.1 ȝ0DQGĮȕ-methyleneATP ȝ0 
(n=10), B) of prazosin (0.1 ȝ0 and RX811059 (1 µM) (n=4), or C) of prazosin (0.1 ȝ0 DQG
BIBP3226 (1 µM) (n=7), on responses to electrical field stimulation (2-32 Hz, 1 ms, 30 s, 90 V) in 
porcine mesenteric first order arteries under raised tone conditions. Each bar represents mean ± 
standard error. Responses after prazosin were significantly inhibited in all sets of experiments. # P < 
0.001 vs. prazosin (ANOVA followed by Bonferroni post-hoc test). 
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Fig. 4.10 Effects of the sequeQWLDODGGLWLRQRI5;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0DQGĮȕ-methyleneATP (1 
ȝ0 (n=7), on contractile responses to electrical field stimulation (2-32 Hz, 1 ms, 30 s, 90 V) 
in porcine mesenteric first order arteries under raised tone conditions. Each bar represents 
mean ± standard error. ** P < 0.01, *** P < 0.001 vs. control (ANOVA followed by 
Bonferroni post-hoc test). 
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Fig. 4.11 Reproducibility of contractile responses to electrical field stimulation (2-32 Hz, 1ms, 30s, 
90 V). Open bars show the first frequency response curve (FRC 1), while the closed bars show the 
second frequency response curve (FRC 2) and the striped bars show the third frequency response 
curve (FRC 3) (n=5) in porcine mesenteric third order arteries under basal tone conditions. Each 
bar represents mean ± standard error. 
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Fig. 4.12 Effects of the sequential addition of A) prazosin (0.1 ȝ0DQGJXDQHWKLGLQHȝ0 
(n=6), or B) Įȕ-methyleneATP ȝ0 (n=6), on responses to electrical field stimulation (2-
32 Hz, 1 ms, 30 s, 90 V) in porcine mesenteric third order arteries under basal tone conditions. 
Each bar represents mean ± standard error. ** P < 0.01, *** P < 0.001 vs. control (ANOVA 
followed by Bonferroni post-hoc test). 
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Fig. 4.13 Contractile responses to electrical field stimulation (2-32 Hz, 1 ms, 30s, 90 V) in 
porcine mesenteric third order arteries under basal tone conditions (control), and in the 
presence of U46619 (n=5). Each bar represents mean ± standard error. + shows a 
significant difference between curves (P < 0.05, ANOVA followed by Bonferroni post-hoc 
test). 
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Fig. 4.14 Effects of A) the sequential addition of prazosin (0.1 ȝ0DQGJXDQHWKLGLQH(1 
ȝ0 (n=6), or B Įȕ-methyleneATP  ȝ0 (n=7), on responses to electrical field 
stimulation (2-32 Hz, 1ms, 30s, 90 V) in porcine mesenteric third order arteries under 
raised tone conditions. Each bar represents mean ± standard error. * P < 0.05, ** P < 
0.01, *** P < 0.001 vs. control. # P < 0.001 vs. prazosin (ANOVA followed by 
Bonferroni post-hoc test). 
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Fig. 4.15 Responses to Įȕ-methyleneATP (1 µM) (n=8) in porcine mesenteric first order arteries 
under basal tone conditions. Each bar represents mean ± standard error. * P < 0.05 vs. first response 
6WXGHQW¶VSDLUHGW-test). 
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Fig. 4.16 A) 5HVSRQVHVWRĮȕ-PHWK\OHQH$73ȝ0in the absence of drugs (control), or in 
the presence of nifedipine (1 µM) (n=8) under basal tone conditions in porcine mesenteric 
first order arteries. Each bar represents mean ± standard error. B) Representative trace 
showing responses to Įȕ-PHWK\OHQH$73  ȝ0 in the absence and in the presence of 
nifedipine ȝ0 under basal tone conditions in porcine mesenteric first order arteries.  
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 15 min 
Fig. 4.17 A) Responses to RI Įȕ-PHWK\OHQH$73  ȝ0 XQGHU EDVDO WRQH FRQGLWLRQV
(control) or in the presence of U46619 (n=8) in porcine mesenteric first order arteries. Each 
bar represents mean ± standard error. *** P < 0.001 vs. control 6WXGHQW¶VSDLUHGW-test). B) 
Representative trace showing the response to Įȕ-PHWK\OHQH$73  ȝ0 XQGHU EDVDO WRQH
conditions and a larger response under conditions of raised tone, in porcine mesenteric first 
order arteries. 
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Fig. 4.18 Responses to Įȕ-mHWK\OHQH$73ȝ0XQGHU raised tone conditions (control) or in the 
presence of nifedipine (1 µM) (n=8) in porcine mesenteric first order arteries. Each bar represents 
mean ± standard error. ** P < 0.01 vs. control 6WXGHQW¶Vunpaired t-test). 
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Fig. 4.19 Responses to single application RIĮȕ-PHWK\OHQH$73ȝ0XQGHUEDVDOWRQHFRQGLWLRQV
(control) or in the presence of endothelin-1 (1-2 nM) (n=9) in first order porcine mesenteric arteries. 
Each bar represents mean ± standard error. * P < 0.5 vs. control 6WXGHQW¶VSDLUHGW-test). 
Control Endothelin-1
0
1
2
3
4
*
*
 1PM D ,E -methyleneATP
Is
o
m
et
r
ic
 
te
n
si
o
n
 
(g
)
 
4. Sympathetic neurotransmission in porcine isolated arteries 
108 
 
 
 
 
        A) 
 
 
 
 
 
 
 
      B) 
 
 
 
 
 
 
 
 
 
 
Control U46619
0
1
2
3
4
5
6 *
*
1PM Noradrenaline
Is
o
m
et
r
ic
 
te
n
si
o
n
 
(g
)
 
K
C
l  
60
 m
M
8
10
6
4
2
Is
o
m
et
ri
c 
te
n
si
on
 
(g
)
0
W
a
sh
 
o
u
t
U
46
61
9
W
a
sh
 
o
u
t
N
or
a
dr
en
a
lin
e 
(1
 µ
M
)
N
or
a
dr
en
a
lin
e 
(1
 µ
M
)
 
Fig. 4.20 A) Responses to exogenous noradrenaline (1µM) (n=8) under basal tone conditions 
(control) or in the presence of U46619 (15-20 nM) in porcine mesenteric first order arteries. 
Each bar represents mean ± standard error. ** P < 0.01 vs. control 6WXGHQW¶VSDLUHGW-test). B) 
Representative trace showing the effect of single concentration application of NA  ȝ0
under basal tone conditions and a larger response under conditions of raised tone, in porcine 
mesenteric first order arteries. 
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Fig. 4.21 A) Responses to exogenous noradrenaline (0.3 µM) (n=8) under basal tone 
conditions (control) or in the presence of U46619 (15-25 nM) in porcine mesenteric first order 
arteries. Each bar represents mean ± standard error. ** P < 0.01 vs. control 6WXGHQW¶VSDLUHGW-
test). B). Representative trace showing the response to noradrenaline (0.3 µM) under basal 
tone conditions and a larger response under conditions of raised tone, in porcine first order 
mesenteric arteries. 
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Fig. 4.22 Effects of Įȕ-PHWK\OHQH$73ȝ0 on the responses to electrical field stimulation (32 
Hz, 1ms, 30s, 90 V) in porcine mesenteric third order and first order arteries under raised tone 
conditions (n=9). Each bar represents mean ± standard error. P > 0.05 (Mann-Whitney test). 
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4.5 DISCUSSION  
The main finding of the present chapter is, that under conditions in which tone 
was raised with U46619, ATP has contributed to the mediation of the 
electrically-evoked contractile response in porcine first and third order 
mesenteric arteries. In contrast ATP had no involvement under basal tone 
conditions. Responses to Įȕ-methyleneATP and exogenous NA were 
enhanced under raised tone conditions indicating the involvement of a 
postjunctional mechanism in the larger responses seen under raised tone 
conditions. 
First order arteries 
In porcine first order mesenteric arteries, under basal tone conditions 
electrically-evoked contractions were reproducible. TTX and guanethidine 
virtually abolished the electrically-evoked contractile responses, indicating that 
the responses were neurogenic and sympathetic in origin. Prazosin inhibited 
the electrically-evoked contractile responses to a similar extent to TTX or 
guanethidine, while Įȕ-methyleneATP did not alter the responses. These 
observations show that NA is the main sympathetic neurotransmitter acting via 
Į1-adrenoceptors in porcine mesenteric first order arteries under basal tone 
conditions. 
Under raised tone conditions, the nerve-mediated responses were slightly 
enhanced. Guanethidine virtually abolished the electrically-evoked contractile 
responses in porcine mesenteric first order arteries, under these conditions. In 
contrast, there was a significant residual component remaining in the presence 
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of prazosin. This suggests that another transmitter or receptor mechanism is 
functional under raised tone conditions. One possibility is Į2-adrenoceptors. 
These receptors have been shown to be involved in mediating postjunctional 
effects of neuronally-derived NA, but only in the presence of an unrelated 
agonist such as angiotensin II, as shown for example in the rabbit distal 
saphenous artery (Dunn et al., 1991b). The data obtained in the present study 
indicate some involvement of Į2-adrenoceptors in mediate the neurogenic 
contractile responses in porcine mesenteric arteries under both raised and basal 
tone conditions, since RX811059, an Į2-adrenoceptor antagonist, inhibited the 
electrically-evoked contractile responses. However, the addition of RX811059 
after prazosin under raised tone conditions did not affect the prazosin-resistant 
component of the response. It should be noted that the interpretation of 
RX811059 effects might be complicated by its possible prejunctional actions 
(disinhibition of neurotransmitter release) which might lead to an 
underestimation of the role of postjunctional Į2-adrenoceptors in causing 
contraction. 
In chapter 3 I demonstrated that ATP was involved in mediation of the 
electrically-evoked vasoconstrictor responses in the porcine perfused bed 
under raised tone conditions. Thus, to investigate the involvement of ATP, Įȕ-
methyleneATP, a P2X1 receptor desensitising agent ZDV XVHG Įȕ-
methyleneATP had a significant inhibitory effect on responses to EFS only in 
the presence of U46619, while under basal tone conditions it had no significant 
effect. This indicates that while NA is the main neurotransmitter acting mostly 
through Į1-adrenoceptors, ATP contributes to part of the response through 
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activation of P2X1 receptors, under raised tone conditions only. This is 
essentially the same observation as made in the perfused mesenteric bed (see 
chapter 3). 
The other possibility is an altered function of NPY as a sympathetic co-
transmitter under raised tone conditions (Lundberg et al., 1983). Raising the 
tone can enhance NPY responses, for example, small responses to exogenous 
NPY were obtained under basal tone conditions which were enhanced in the 
presence of U46619 in porcine isolated ear artery (Roberts et al., 1999). 
However, the NPY Y1 receptor antagonist BIBP3226 had no significant effect 
on electrically-evoked contractile responses under conditions of raised tone 
indicating that Y1 receptors were not involved in the enhanced nerve response 
in porcine mesenteric arteries. This perhaps is not surprising since, for the most 
part, NPY acts as a neuromodulator with little or no postjunctional actions, 
although in some vessels, especially in cerebral arteries, it can produce 
vasoconstrictor responses (Fredholm et al., 1985, Edvinsson et al., 1994). 
Thus, it seems that porcine mesenteric arteries differ from cerebral arteries in 
terms of the involvement of NPY as a sympathetic neurotransmitter. These 
data demonstrate that under raised tone conditions, NA mediates contractions 
by activating SRVWMXQFWLRQDO Į1-DGUHQRFHSWRUV DQG Į2-adrenoceptors and that 
ATP via P2X receptors is also involved in mediating sympathetic-nerve 
mediated responses in these vessels. 
EFS can stimulate not only sympathetic nerves but also sensory nerves. 
Activation of sensory nerves can cause vasodilatation in some vascular beds by 
releasing different neurotransmitters principally calcitonin gene-related peptide 
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(CGRP) (Kawasaki et al., 1988). Capsaicin acts by stimulating transient 
receptor potential vanilloid receptor type 1 (TRPV1) receptors located on 
capsaicin-sensitive sensory nerves (Gupta et al., 2007). The exposure of 
sensory nerves to capsaicin desensitizes and depletes them of their 
neurotransmitters (Maggi and Meli, 1988, Caterina and Julius, 2001). In the 
present study pre-treatment with capsaicin had no significant effect on the size 
of the electrically-evoked contractile responses in porcine mesenteric first 
order arteries. These results are similar to those obtained in the porcine 
perfused bed (see chapter 3) but different from those obtained in the rat 
perfused mesenteric bed. In the rat perfused mesenteric bed EFS produced a 
two-phase response vasoconstrictor and vasodepressor responses (Pakdeechote 
et al., 2007). Pre-treatment with capsaicin abolished the vasodepressor 
response and enhanced the electrically-evoked vasoconstrictor responses 
indicating an involvement of sensory nerves (Pakdeechote et al., 2007). The 
simple explanation could be a difference between the species. 
Third order arteries 
A very similar pattern to that seen with first order vessels was seen in third 
order arteries. Under basal tone conditions, electrically-evoked contractions 
were reproducible and sympathetic in origin since guanethidine almost 
abolished them. Prazosin had a similar effect to that of guanethidine, indicating 
that electrically-evoked contractions were mediated by NA acting through 
SRVWMXQFWLRQDOĮ1-DGUHQRFHSWRUV)XUWKHUPRUHĮȕ-methyleneATP had no effect 
on electrically-evoked contractile responses indicating that P2X receptors were 
not involved in the mediation of these responses. 
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U46619 enhanced the nerve-mediated responses. In the presence of U46619, 
guanethidine was more effective at blocking responses than prazosin especially 
at higher frequencies, showing that while NA was still the major 
QHXURWUDQVPLWWHU DFWLQJ YLD Į1-adrenoceptors, some other mechanism was 
LQYROYHG 7KLV ZDV PRVW OLNHO\ $73 VLQFH Įȕ-methyleneATP significantly 
inhibited the electrically-evoked contractile responses in third order arteries in 
the presence of U46619. 
Data obtained in the present study showed that responses to exogenous NA or, 
WKH DQDORJXH RI $73 Įȕ-methyleneATP, were enhanced under raised tone 
conditions. Furthermore, our results showed that responses WR Įȕ-
methyleneATP were enhanced not only in the presence of U46619 but also in 
the presence of endothelin-1. These results are consistent with the results 
obtained in the rat perfused mesenteric bed wheUH UHVSRQVHV WR Įȕ-
methyleneATP and EFS were enhanced in the presence of either U46619 or 
endothelin-1 (Pakdeechote et al., 2007). Thus, enhancement not specific to 
U46619 but a consequence of the increase in tone. 
The fact that the overall response to EFS gets bigger is due, at least in part, to 
the uncovering of a purinergic response as evidenced by the inhibitory effect of 
Įȕ-methylene at raised but not at basal tone conditions and by the enhanced 
contractions to Įȕ-methylene. P2X receptor activation leads to a direct influx 
of cations into the cell and depolarization of the smooth muscle leading to the 
opening of voltage-sensitive calcium channels (Lagaud et al., 1996). Voltage-
sensitive calcium channels have been shown to be involved in mediating 
purinergic vasoconstriction in blood vessels including canine mesenteric 
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arteries and rabbit ileocolic arteries (Omote et al., 1989, Bulloch et al., 1991). 
To investigate the role of voltage-sensitive calcium channels in the mediation 
of the responses to Įȕ-methyleneATP, the L-type calcium channel blocker 
nifedipine was used. Nifedipine had no significant effect on responses to Įȕ-
methyleneATP under conditions of basal tone but reduced responses after 
raising tone with U46619. This may indicate that voltage-sensitive calcium 
channels were involved in P2X receptors-mediated contractions only under 
conditions of raised tone. It has been demonstrated that U46619 depolarizes 
vascular smooth muscle (Crane and Garland, 2004, Shaw et al., 2004) and this 
may provide conditions where further depolarization caused by ATP acting on 
P2X receptors results in further opening of L-type Ca2+ channels and thus 
contraction. The change in membrane potential may explain the enhanced 
response and the uncovering of a purinergic response under raised tone 
conditions as described in pressurised arteries (Rummery et al., 2007).  
In the current study there was an enhancement of responses to exogenous NA 
in pre-constricted arteries. It is possible that this enhancement may be due to 
an the additional involvement of postjunctional Į2-adrenoceptors under raised 
WRQH FRQGLWLRQV VLQFH Į2-adrenoceptors have been shown to be involved in 
mediating postjunctional effects of neuronally-derived NA, especially in the 
presence of an agonist such as angiotensin II, in the rabbit distal saphenous 
artery (Dunn et al., 1989, Dunn et al., 1991b) and parallels results obtained in 
this present study where there was some evidence for an involvement of Į2-
adrenoceptors in neurogenic responses at raised tone. Another possibility is the 
involvement of voltage-sensitive calcium channels in the mediation of the 
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enhanced noradrenergic response since there is evidence supporting the 
dependence of Į2-adrenoceptors upon an influx of extracellular calcium 
through voltage-sensitive calcium channels (McGrath et al., 1989, Dunn et al., 
1991a). 
One of the aims in studying first and third order arteries was to determine if the 
role of ATP as a sympathetic neurotransmitter increased as arteries got smaller 
(Gitterman and Evans, 2001). However, a comparison between the effect of 
Įȕ-methyleneATP on the electrically-evoked contractile responses in first and 
third order arteries showed no difference. This may indicate that although first 
and third order arteries have a purinergic component, other parts of the 
vascular tree (smaller arteries) may be involved in the uncovering of the 
purinergic response observed at raised tone in the whole bed preparation, since 
the purinergic component shown in first and third arteries under raised tone 
conditions is modest compared to that obtained in the porcine perfused bed at 
raised tone. Thus, chapter 5 studied smaller arteries using isometric myograph 
techniques. 
In conclusion the present study has shown that, in porcine first and third order 
mesenteric arteries, pre-constriction with U46619 uncovered the involvement 
of ATP as a neurotransmitter acting through P2X receptors, which was not 
evident under basal tone conditions, while NA acts as the main 
neurotransmitter DFWLQJSULQFLSDOO\YLDSRVWMXQFWLRQDOĮ1-adrenoceptors with a 
smaller coQWULEXWLRQ RI Į2-adrenoceptors both under basal and raised tone 
conditions. 
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5 CHARACTERIZATION OF SYMPATHETIC 
NEUROTRANSMISSION IN PORCINE SMALL 
MESENTERIC ARTERIES 
5.1 INTRODUCTION 
In chapter 4 I demonstrated a small purinergic component in the response to 
EFS in porcine first and third order mesenteric arteries under raised tone 
conditions. However, the size of the purinergic component uncovered by 
raising tone in the porcine perfused bed described in chapter 3, was more 
substantial indicating that some other part of the vascular tree comprising the 
mesenteric arterial bed was more probably contributing. Furthermore, it has 
been demonstrated that the purinergic component of responses to nerve 
stimulation becomes more important in smaller arteries (Gitterman and Evans, 
2001). 
The aim of the present chapter was to characterize sympathetic 
neurotransmission in the porcine mesenteric small resistance arteries using 
wire myography.  
5.2 MATERIALS AND METHODS 
5.2.1 Tissue preparation for immunohistochemical staining  
Porcine mesenteries were obtained as described in section 2.1. Fine dissection 
was carried out to identify small terminal branch arteries using a dissecting 
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microscope. Porcine mesenteric small arteries were then used for either 
immunohistochemical staining as described in section 2.3 or wire myography 
as described in section 2.4. 
5.2.2 Response to EFS in porcine mesenteric small arteries under basal 
tone conditions 
After an equilibration period of 60 min responses to EFS (2-16 Hz, 1 ms, 10 V, 
30 s) were obtained. The interval between each frequency was variable (2-4 
min), and was determined by the return to baseline after each stimulation. 
Preparations were exposed to prazosin (0.1 µM), after the first FRC, while the 
combination of prazosin 0SOXVĮȕ-methyleneATP (1 µM) was added 
after the second FRC and a third FRC was constructed. All antagonist drugs 
were left for 30 min before testing their effect on the electrically-evoked 
vasoconstrictor responses. 
5.2.3 Response to EFS in porcine mesenteric small arteries under raised 
tone conditions 
After an equilibration period of 60 min, prior to exposing the tissue to EFS, 
U46619 (0.5 - 2 nM), a thromboxane A2 agonist, was used to raise the tone to 
about 25% of the second KCl response. Responses to EFS (2-16 Hz, 1 ms, 10 
V, 30 s) were then determined. In some preparations a FRC was obtained 
under basal tone conditions after which U46619 was added to raise the tone 
and a second FRC was conducted. Other preparations were exposed to 
prazosin (0.1 µM) after the first FRC, while a combination of prazosin (0.1 
0SOXVĮȕ-methyleneATP (1 µM) was added after the second FRC and a 
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third FRC was constructed. The order of drug addition was changed in other 
preparations. 
In some experiments the L-type calcium channel blocker nifedipine (1 µM) 
(Blakeley et al., 1981, Rummery et al., 2007) was added after the second FRC 
before a third FRC was constructed. Antagonist drugs were left for 30 min 
before testing their effect on the electrically-evoked contractile responses. In 
experiments where nifedipine was used the vessels were pre-constricted with 
U46619 to about 35-45% of the second KCl response. Thus, when nifedipine 
was added, the tone of pre-constricted vessels decreased back to 25% of the 
second KCl response. Only after reaching a stable level of pre-constriction, 
was a further FRC constructed. 
 
5.2.4 5HVSRQVHV WR H[RJHQRXV QRUDGUHQDOLQH DQG Įȕ-methyleneATP in 
porcine mesenteric small arteries under basal and raised tone 
conditions 
To assess vascular responsiveness a single concentration of NA (1µM) or Įȕ-
methyleneATP (1 µM) was obtained under basal tone conditions. The tissue 
was washed twice with Krebs-Henseleit buffer for 30 min and U46619 (0.5-2 
nM) was then added to pre-constrict the vessel to about 25% of the second KCl 
response. When a stable contraction to U46619 was achieved, a second 
application of NA (1µM) or Įȕ-methyleneATP (1 µM) was applied. Similar 
experiments were conducted in large arteries. 
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5.3 STATISTICAL ANALYSIS 
Results are expressed as the mean ± S.E.M. Statistical comparisons were made 
by two way analysis of variance (ANOVA) with Bonferroni post-hoc test or 
6WXGHQW¶V paired t-test if the data were normally distributed (checked by 
Shapiro-Wilk normality test) while Mann-Whitney test was used if the data 
were not normally distributed. A value of P < 0.05 was taken to indicate 
statistical significance. 
5.4 RESULTS 
5.4.1 Immunohistochemical characterization of perivascular nerves in 
porcine mesenteric small arteries 
The general neuronal marker protein gene product 9.5 (PGP9.5), a member of 
a gene family whose products hydrolyze small C-terminal adducts of ubiquitin 
to generate ubiquitin monomer, which is highly expressed in neurons, was 
used to visualize nerves within porcine mesenteric small arteries. Nerves 
immunoreactive to PGP9.5 were identified in porcine mesenteric small arteries 
(Fig. 5.1A), while the controls, where primary antibody was not applied, 
showed no binding of the secondary antibody (Fig. 5.1B). 
Tyrosine hydroxylase (TH) is an enzyme involved in the conversion of 
tyrosine to dopamine in the synthesis of catecholamines in sympathetic 
neurons. TH marker was used to visualize noradrenergic nerves within small 
porcine mesenteric arteries. Nerves immunoreactive to TH were identified in 
small porcine mesenteric arteries (Fig. 5.2A), while the controls, where 
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primary antibody was not applied, showed no immunoreactivity to TH (Fig. 
5.2B). 
5.4.2 (IIHFWV RI SUD]RVLQ DQG Įȕ-methyleneATP in porcine mesenteric 
small arteries under basal tone conditions 
Under basal tone conditions EFS produced contractile responses which were 
frequency-dependent. Įȕ-methyleneATP (1 µM) caused a transient 
contraction (0.80 ± 0.07 g, n=7) which returned to the baseline before the 
construction of the next FRC, but had no significant effect on the contractile 
responses to EFS in porcine mesenteric small arteries under basal tone 
conditions (n=7) (Fig. 5.3). Subsequent exposure to prazosin (0.1 µM) 
significantly inhibited the contractile responses to EFS (P < 0.001, ANOVA 
followed by Bonferroni post-hoc test) (n=7) (Fig. 5.3). 
5.4.3 Effects of prazosin and Įȕ-methyleneATP in porcine mesenteric 
small arteries under raised tone conditions 
U46619 (0.5-2 nM) contracted porcine mesenteric small arteries by 20 ± 3% of 
KCl response (n=14). Under raised tone conditions, EFS produced contractile 
responses which were frequency-dependent and larger than under basal tone 
conditions at all frequencies reaching statistical significance at 16 Hz (P < 
0.001, ANOVA followed by Bonferroni post-hoc test) (n=12) (Fig. 5.4). 
Įȕ-methyleneATP (1 µM), a P2X receptor desensitizing agent, caused a 
transient contraction (0.95 ± 0.5 g, n=7) which returned to the baseline before 
the construction of the next FRC. Įȕ-methyleneATP inhibited the responses to 
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nerve stimulation (e.g. at 8 Hz by 41 ± 11% and at 16 Hz by 36 ± 8%) (Fig. 
5.5A) in porcine mesenteric small arteries under raised tone conditions, in 
contrast to its lack of effect under basal tone conditions (see Fig. 5.3). Further 
addition of pUD]RVLQ  0 DQ Į1-adrenoceptor antagonist, abolished the 
response at 2, 4 and 8 Hz leaving a small residual response at 16 Hz (P < 
0.001, ANOVA followed by Bonferroni post-hoc test) (n=7) (Fig. 5.5A) 
presumably due to direct smooth muscle activation. 
When prazosin was added first it almost abolished the response at lower 
frequencies leaving a residual response at higher frequencies which was 
reduced by further addition of Įȕ-methyleneATP (n=5) (Fig. 5.5B). 
5.4.4 Effects of nifedipine in porcine mesenteric small arteries under 
raised tone conditions 
The L-type calcium channel blocker nifedipine (1 µM), decreased the raised 
tone that was produced by U46619 by 15-20% and prevented the enhanced 
responses produced in the presence of U46619 at all frequencies (P < 0.01, 
ANOVA followed by Bonferroni post-hoc test, n=4) (Fig. 5.6), such that in the 
presence of nifedipine responses to EFS were similar to contractile responses 
under basal tone conditions. 
5.4.5 Effects of exogenous noradrenaline in porcine mesenteric small 
arteries under basal and raised tone conditions 
Responses to exogenous NA (1 µM) were enhanced under raised tone 
conditions (n=4) Mann-Whitney test (Fig. 5.7). 
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5.4.6 Comparison of rHVSRQVH WR Įȕ-methyleneATP (1 µM) in porcine 
first order and small mesenteric arteries under basal and raised 
tone conditions  
KCl was used to check the viability and the maximum contractility of vascular 
tissue. KCl (60 mM) contracted both porcine mesenteric small arteries (n=22) 
(Fig. 5.8) and porcine mesenteric first order arteries (n=16) (Fig. 5.9). 
Responses to Įȕ-methyleneATP (1 µM) were significantly enhanced in the 
presence of U46619 in porcine mesenteric small arteries (P < 0.01, one way 
ANOVA) (n=11) (Fig. 5.8). Similarly, responses to Įȕ-methyleneATP (1 µM) 
were enhanced in the presence of U46619 in porcine mesenteric first order 
arteries (*** P < 0.001, one way ANOVA) (n=8) (Fig. 5.9). 
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150 µm 
Fig. 5.1 A representative of maximum projection confocal images of whole-mount 
preparations of porcine mesenteric small arteries. A) Immunoreactive perivascular nerves 
stained for PGP9.5 (red) can be seen. B) When PGP9.5 (primary antibody) was not 
applied (control) perivascular nerves cannot be identified. Scale bar = 150 µm. 
 
150 µm 
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Fig. 5.2 A representative of maximum projection confocal images of whole-mount preparations 
of porcine mesenteric small arteries. A) Immunoreactive perivascular nerves stained for TH 
(green) can be seen. B) When TH (primary antibody) was not applied (control) perivascular 
nerves cannot be identified. Scale bar = 150 µm. 
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Fig. 5.3 (IIHFWV RI WKH VHTXHQWLDO DGGLWLRQ RI Įȕ-PHWK\OHQH$73  ȝ0 followed by 
SUD]RVLQ  ȝ0 (n=7) under basal tone conditions, on responses to electrical field 
stimulation (2-16 Hz, 1 ms, 30 s, 10V) in porcine mesenteric small arteries. Each bar 
represents mean ± standard error. *** P < 0.001 vs. Įȕ-methyleneATP (ANOVA 
followed by Bonferroni post-hoc test). 
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Fig. 5.4 Contractile responses to electrical field stimulation (2-16 Hz, 1 ms, 30 s, 10V) in 
porcine mesenteric small arteries under basal tone conditions (control), and in the presence 
of U46619 (n=12). Each bar represents mean ± standard error. *** P < 0.001 vs. control 
(ANOVA followed by Bonferroni post-hoc test). 
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Fig. 5.5 Effects of the sequential addition of A) Įȕ-PHWK\OHQH$73  ȝ0 followed by 
SUD]RVLQȝ0 (n=7), or %SUD]RVLQȝ0 followed by Įȕ-PHWK\OHQH$73ȝ0(n=5) 
under raised tone conditions, on responses to electrical field stimulation (2-16 Hz, 1 ms, 30 s, 
10V) in porcine mesenteric small arteries. Each bar represents mean ± standard error. * P < 
0.05  3   YV FRQWURO  3   YV Įȕ-methyleneATP (ANOVA followed by 
Bonferroni post-hoc test). 
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Fig. 5.6 Contractile responses to electrical field stimulation (2-16 Hz, 1 ms, 30 s, 10V) in 
porcine mesenteric small arteries under basal tone conditions (control), in the presence of 
U46619 or in the presence of nifedipine ȝ0 (n=4). Each bar represents mean ± standard 
error. * P < 0.01 vs. U46619 (ANOVA followed by Bonferroni post-hoc test). 
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Fig. 5.7 Responses to exogenous QRUDGUHQDOLQH  ȝ0 Q  XQGHU EDVDO WRQH FRQGLWLRQV
(control) or in the presence of U46619-induced tone in porcine mesenteric small arteries. Each bar 
represents mean ± standard error. * P < 0.05 vs. control (Mann Whitney test). 
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Fig. 5.8 Responses to KCl (60 mM) (n=22) (basal tone) and Įȕ-PHWK\OHQH$73ȝ0 (n=11) 
under basal or raised tone conditions in porcine mesenteric small arteries. Each bar represents 
mean ± standard error. * P < 0.05 vs. basal tone conditions (one way ANOVA). 
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Fig. 5.9 Responses to KCl (60 mM) (basal tone) (n=16) and Įȕ-PHWK\OHQH$73  ȝ0 (n=8) 
under basal or raised tone conditions in porcine mesenteric first order arteries. Each bar represents 
mean ± standard error. *** P < 0.001 vs. basal tone conditions (one way ANOVA). 
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5.5 DISCUSSION 
Immunohistochemical staining of porcine mesenteric small arteries showed the 
presence of substantial innervation with perivascular nerves where fibres 
immunoreactive to PGP 9.5 were identified. Staining with TH revealed an 
abundance of sympathetic nerves among these perivascular nerves. Similar 
observations have been reported in human mesenteric arteries where 
immunoreactive fibres at the adventitial-medial border were identified (Birch 
et al., 2008). 
Functional studies of the porcine mesenteric small arteries obtained in the 
present study have demonstrated that ATP is an important sympathetic 
neurotransmitter in porcine mesenteric small arteries. This was apparent since 
Įȕ-methyleneATP inhibited the nerve-mediated response under conditions of 
UDLVHG WRQHRQO\ LQFRQWUDVW WR WKH ODFNRIHIIHFWRIĮȕ-methyleneATP under 
basal tone conditions, where nerve-PHGLDWHG UHVSRQVHV ZHUH UHVLVWDQW WR Įȕ-
methyleneATP but almost completely abolished by prazosin. These results 
indicate that ATP is not involved as a sympathetic cotransmitter under basal 
tone conditions and most of the response was mediated by NA acting via 
SRVWMXQFWLRQDOĮ1-adrenoceptors.  
7KHUHVLVWDQW WRĮȕ-methyleneATP under basal tone conditions in the current 
study has also been observed in the porcine perfused arterial bed, and first and 
third order arteries, but contradict another observation in rat small mesenteric 
arteries under basal tone conditions, where ATP has been shown to be the 
dominant sympathetic neurotransmitter (Gitterman and Evans, 2001). While 
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this may be explained as a difference between species a more likely 
explanation is that different experimental conditions employed may affect the 
purinergic component of the sympathetic response, since in the rat perfused 
mesenteric arterial bed there was no role for ATP as a sympathetic 
cotransmitter under basal tone conditions tone (Pakdeechote et al., 2007). 
Under conditions of raised tone using U46619, the nerve-mediated responses 
EHFDPH ODUJHU )XUWKHUPRUH UHVSRQVHV WR H[RJHQRXVO\ DSSOLHG 1$ DQG Įȕ-
methyleneATP were enhanced. This suggests a postjunctional mechanism of 
enhancement to both components of sympathetic neurotransmission; 
noradrenergic and purinergic. These observations have also been shown in 
studies where U46619 enhanced the responses to nerve-mediated and 
exogenously applied NA in human saphenous vein (Vila et al., 2001). 
Responses to Įȕ-methyleneATP have also been enhanced in the presence of 
U46619 in the rat perfused mesentery (Pakdeechote et al., 2007). Moreover, 
these results parallel my observations in chapter 4 in isolated first order arteries 
ZKHUHWKHUHVSRQVHVWRERWK1$DQGĮȕ-methyleneATP were enhanced in the 
presence of U46619. Further investigations under raised tone conditions 
showed that the nerve-mediated responses were inhibited by either prazosin or 
Įȕ-methyleneATP showing the involvement of NA and ATP in the mediation 
of the neurogenic response. 
In chapter 4 I demonstrated that L-type Ca2+ cannels were involved in the 
PHGLDWLRQ RI WKH UHVSRQVHV Įȕ-methyleneATP under raised tone conditions. 
Therefore, in the present study I examined a possible involvement of L-type 
Ca2+ cannels in the mediation of nerve-mediated responses in porcine 
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mesenteric small arteries. Nifedipine inhibited the enhanced responses in the 
presence of U46619 indicating that L-type Ca2+ channels may have role in the 
mediation of the enhanced responses in porcine mesenteric small arteries. 
However, other studies have shown no role for L-type Ca2+ channels in 
response to neuronally evoked purinergic response in rat small mesenteric 
arteries, and it was suggested that enough calcium enters the cell through P2X 
receptors to cause contraction (Gitterman and Evans, 2001). Similar results 
were also observed for H[RJHQRXVO\DSSOLHGĮȕ-methyleneATP, for example, 
in submucosal arterioles of guinea pig ileum (Galligan et al., 1995). It should 
be noted that these experiments were conducted under basal tone conditions; 
indeed they are consisting with the results obtained in chapter 4 where it has 
been shown that L-type Ca2+ cannels were not involved in the mediation of the 
response to Įȕ-methyleneATP since nifedipine failed to inhibit the responses 
under basal tone conditions. These results demonstrate that the role of P2X 
receptors and voltage-sensitive calcium channels can be underestimated in the 
absence of appropriate tone conditions which may explain the absence of the 
purinergic component of the nerve-mediated responses obtained in this present 
study under basal tone conditions. 
One of the aims of the present study was to compare the size of the purinergic 
component in porcine mesenteric first order and small sized arteries. Data 
obtained in the present study clearly demonstrated that the purinergic response 
increases as the size of the arteries decreases tone. This is in line with the 
demonstration that in rat large (first order) mesenteric arteries P2X receptors 
were about 100 times less sensitive to agonist (Įȕ-methyleneATP) than in 
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smaller arteries , attributed to an increased number of P2X receptors in the 
small arteries (Gitterman and Evans, 2000). Furthermore, this is consistent 
with results obtained in rat mesenteric arteries where the purinergic component 
of EFS was larger as the size of the arteries decreases (Gitterman and Evans, 
2001). On the other hand, smaller purinergic response in large arteries should 
not be a surprise, as it has been demonstrated using [3+@ Įȕ-methyleneATP 
radioligand, that in rat, guinea pig and human pulmonary arteries the density of 
P2X receptors was higher in medium- and small-sized arteries than in that of 
large arteries (Zhao et al., 1996). 
In conclusion, data obtained in the current study showed that under conditions 
of raised tone the nerve-mediated response was enhanced through the 
enhancement of purinergic and noradrenergic component via a postjunctional 
mechanism. This enhancement was in association with L-type Ca2+ channels. 
The purinergic response of porcine mesenteric arteries is more evident as the 
size of the arteries becomes smaller. 
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6 PRE-CONSTRICTION INCREASES NERVE-
MEDIATED RESPONSES IN RAT 
PRESSURIZED MESENTERIC ARTERIES  
6.1 INTRODUCTION 
In vivo, blood vessels constrict on the background of variable degrees of 
intraluminal pressure. It has been demonstrated that exposing blood vessels to 
different levels of blood pressure alters vascular responsiveness. For example, 
increasing pressure from 20 mmHg to 60 mmHg enhanced the sensitivity of 
responses to noradrenaline in rabbit mesenteric arteries (Dunn et al., 1994). 
With regard to nerve-mediated responses, increasing the intraluminal pressure 
from 30 mmHg to 90 mmHg in rat mesenteric arteries made responses larger 
and revealed a predominant functional role for adenosine triphosphate (ATP) 
as the sympathetic neurotransmitter in rat mesenteric arteries (Rummery et al., 
2007). In chapter 3, 4 and 5 I demonstrated that raising tone with U46619, a 
thromboxane mimetic agent, enhanced the responses to EFS and exogenous 
NA and Įȕ-methyleneATP in porcine mesenteric arterial bed and different 
sized porcine mesenteric arteries. Thus it seems that both pressure and tone 
play an important role in the sympathetic control of blood vessels. Therefore, 
the aim of the present study was to investigate the responses to nerve 
stimulation and the contribution of NA and ATP in rat or porcine small 
mesenteric arteries under the combined effects of pressure with or without pre-
constriction using U46619. 
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6.2 MATERIALS AND METHODS 
6.2.1 Rat mesenteric arteries preparation 
Male Wistar rats (200±250 g) were stunned by a blow to the cranium and 
killed by exsanguination. Second order mesenteric arteries were set up for 
pressure myograph recording as described in section 2.5. 
6.2.2 Porcine mesenteric arteries preparation 
Porcine mesenteries were obtained as described in section 2.1. Fine dissection 
was carried out to identify the small terminal branch arteries using a dissecting 
microscope. The porcine arteries were then set up as described in section 2.6. 
6.2.3 Responses to EFS in rat pressurized mesenteric arteries under 
basal tone conditions 
Following a 20 min equilibration period, arteries were stimulated at 10 Hz (50 
pulses) at 5 min intervals and the stimulation voltage was progressively 
increased until the maximal response was produced, usually between 10-20 V. 
Frequency response curves (FRCs) to 50 pulses at frequencies of 0.5, 2 and 10 
Hz were then constructed. Following each train of stimuli, the diameter of the 
artery was allowed to return to the baseline value before the next stimulus was 
applied. Two FRCs were obtained, at intervals of 30 min, in the absence of 
drugs to act as time controls. In some experiments, after the first FRC 
(control), YM-12617 (0.1 µM), an Į1-adrenoceptor antagonist, or NF 449 (0.1 
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µM), a P2X1 receptor antagonist, were added to examine their effect on 
electrically-evoked vasoconstrictor responses. These concentrations of 
antagonists were chosen since they have previously been shown to selectively 
antagonise Į1-adrenoceptor and P2X-receptor-mediated functional responses in 
mesenteric arteries (Fujii and Kuriyama, 1985, Braun et al., 2001, Kassack et 
al., 2004). YM-12617 was used instead of prazosin because preliminary 
experiments showed that prazosin sticks to the tubing of the pressure 
myograph system making it difficult to wash it out.  
6.2.4 Responses to EFS in rat pressurized mesenteric arteries under 
raised tone conditions 
The thromboxane A2 agonist U46619 (2-10 nM) was used to reduce the 
diameter of pressurized arteries held at 90 mmHg, by about 15 ± 20% of their 
initial diameter. In the presence of U46619, two FRCs were constructed to 
investigate the reproducibility of the electrically-evoked vasoconstrictor 
responses. In some experiments, after the first FRC (control), YM-12617 or 
NF 449 were added to test their effect on electrically-evoked vasoconstrictor 
responses. Both YM-12617 and NF 449 were perfused for 30 min before 
constructing the second FRC. 
6.2.5 Responses to exogenous noradrenaline and Įȕ-methyleneATP in 
rat pressurized mesenteric arteries under basal and raised tone 
conditions 
A concentration response curve (CRC) to exogenous NA was constructed 
under basal tone conditions, in rat mesenteric arteries held at 90 mmHg. The 
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tissue was then washed with physiological salt solution for 30 min, during 
which the perfusate was circulated to waste. U46619 was then added to pre-
constrict the vessels by about 15 ± 20% of their initial diameter. When a stable 
contraction to U46619 was achieved a second CRC to NA was constructed. 
In separate experiments a single concentration of Įȕ-methyleneATP (0.1 µM) 
was added under basal tone conditions in rat mesenteric arteries held at 90 
mmHg. The tissue was then washed with physiological salt solution for 30 min 
during which the perfusate was circulated to waste. U46619 was then added to 
pre-constrict the vessel by about 15% ± 20% of their initial diameter. When a 
stable contraction to U46619 was achieved a second single application of Įȕ-
methyleneATP (0.1 µM) was applied. Similar experiments were carried out in 
porcine small mesenteric arteries. Unfortunately, no response to EFS was 
observed in these vessels, although they did respond to Įȕ-methyleneATP. 
6.3 STATISTICAL ANALYSIS 
Results are expressed as the mean ± S.E.M. Statistical comparisons were made 
by two way analysis of variance (ANOVA) with Bonferroni post-hoc test or 
6WXGHQW¶V paired t-test if the data were normally distributed (checked by 
Shapiro-Wilk normality test) while Mann-Whitney test was used if the data 
were not normally distributed. A value of P < 0.05 was taken to indicate 
statistical significance. 
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6.4 RESULTS 
6.4.1 (IIHFWV RI Į1-adrenoceptor and P2X1 receptor antagonists on 
vasoconstrictor responses to EFS in rat pressurized mesenteric 
arteries under basal tone conditions 
The inner diameter of the second-order mesenteric arteries pressurized to 90 
PP+JZDVȝP (n =33). There was no spontaneous decrease in vessel 
diameter during the equilibration period. EFS of the perivascular nerves 
produced vasoconstrictor responses that increased in amplitude with an 
increase in stimulation frequency. Under basal tone conditions, two FRCs were 
reproducible (n=7) (Fig. 6.1). YM-12617 (0.1 µM), an Į1-adrenoceptor 
antagonist, almost abolished the response at 0.5 and 2 Hz and significantly 
inhibited the electrically-evoked vasoconstrictor responses at 10 Hz (by 83 ± 
6%, P < 0.001, ANOVA followed by Bonferroni post-hoc test) (n=4) (Fig. 
6.2A). NF 449 (0.1 µM), a P2X1 receptor antagonist, was less effective but 
substantially inhibited the electrically-evoked vasoconstrictor responses at 10 
Hz (by 70 ± 8%, P < 0.001, ANOVA followed by Bonferroni post-hoc test) 
(n=7) (Fig. 6.2B). 
6.4.2 (IIHFWV RI Į1-adrenoceptor and P2X1 receptor antagonists on 
vasoconstrictor responses to EFS in rat pressurized mesenteric 
arteries under raised tone conditions 
U46619 (2-10 nM) reduced the internal diameter of the rat pressurized 
mesenteric arteries (by 21 ± 5%) and enhanced responses to EFS at all 
frequencies (e.g. by 100 ± 19% at 10 Hz, P < 0.001, ANOVA followed by 
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Bonferroni post-hoc test) (n=14) (Fig. 6.3A and B). Under raised tone 
conditions two FRCs were reproducible (n=10) (Fig. 6.4). YM-12617 (0.1 µM) 
inhibited the vasoconstrictor responses to EFS (by 65 ± 9% at 10 Hz, P < 
0.001, ANOVA followed by Bonferroni post-hoc test) (n=8) (Fig. 6.5A). 
However, there was a larger YM-12617-resistant component than that evident 
under basal tone conditions. NF 449 (0.1 µM) inhibited the electrically-evoked 
vasoconstrictor responses (by 53 ± 10% at 10 Hz, P < 0.001, ANOVA 
followed by Bonferroni post-hoc test) (n=5) (Fig. 6.5B) to a similar extent to 
that seen under basal conditions (Fig. 6.2B). 
6.4.3 Responses to exogenous 1$ DQG Įȕ-methyleneATP in rat 
pressurized mesenteric arteries under basal and raised tone 
conditions 
Exogenous NA produced vasoconstrictor responses which were concentration-
dependent. After inducing tone with U46619 these responses were enhanced 
(e.g. from 50 ± 17 ȝP to 174 ȝPDW0 of NA, P < 0.001, ANOVA 
followed by Bonferroni post-hoc test) (n=5) (Fig. 6.6A and B). Similarly, 
UHVSRQVHVWRĮȕ-methyleneATP ȝ0ZHUHLQFreased (P < 0.01, 6WXGHQW¶V
paired t-test) (n=7) (Fig. 6.7A and B) in the presence of U46619. 
6.4.4 (IIHFWV RI Įȕ-methyleneATP in the porcine small mesenteric 
arteries pressurized at 90 mmHg under basal and raised tone 
conditions 
Although I demonstrated in chapter 5 that porcine small mesenteric arteries 
were rich in sympathetic perivascular nerves (see Fig. 5.2A) and they 
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responded to EFS under isometric conditions, I failed to evoke vasoconstrictor 
responses to EFS in the pressurised small porcine mesenteric arteries. 
However, U46619 contracted the porcine small mesenteric arteries by 109 ± 49 
ȝP)XUWKHUPRUH Įȕ-methyleneATP ȝ0produced a contraction in these 
vessels that was increased although statistically it was not significant (P > 0.05 
Mann Whitney test) (n=4) (Fig. 6.8) in the presence of U46619-induced tone.  
There is no clear reason to why the porcine pressurised arteries did not respond 
to EFS. It may be that the lack of fat and connective tissues that covers the 
vessel to enable a tight seal in the suction electrode was insufficient. 
Nevertheless, in some experiments small responses to EFS could be generated 
but only at a very high voltage and with high frequencies and these were not 
sensitive to guanethidine.  
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Fig. 6.1 Reproducibility of vasoconstrictor responses to electrical field stimulation (0.5-10 
Hz, 50 pulses, 10-20 V) at 90 mmHg. Opened bars show the first frequency response curve 
(FRC 1) while closed bars show second frequency response curve (FRC 2) (n=7) in rat 
pressurized mesenteric arteries under basal tone conditions. Each bar represents mean ± 
standard error. 
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Fig. 6.2 Effects of A) YM-12617 ȝ0Q RUB) NF499 (0.1 µM) (n=7), on responses 
to electrical field stimulation (0.5-10 Hz, 50 pulses, 10-20 V) mmHg in rat mesenteric arteries 
pressurized to 90 mmHg under basal tone conditions. Each bar represents mean ± standard 
error. ** P < 0.01, *** P < 0.001 vs. control (ANOVA followed by Bonferroni post-hoc test). 
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Fig. 6.3 A) Representative trace showing neuronally evoked contractile responses under basal tone 
conditions and in the presence of U46619 in rat mesenteric arteries pressurised at 90mmHg. B) 
Summary data of contractile responses to electrical field stimulation (0.5-10 Hz, 50 pulses, 10-20 V) 
under basal tone conditions (control), and in the presence of U46619 (2-10 nM) (n=14) in rat 
mesenteric arteries pressurized to 90 mmHg. Each bar represents mean ± standard error.* P < 0.05, 
*** P < 0.001 vs. control (ANOVA followed by Bonferroni post-hoc test).  
10 min 
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Fig. 6.4 Reproducibility of vasoconstrictor responses to electrical field stimulation (0.5-10 Hz, 
50 pulses, 10-20 V) at 90 mmHg. Opened bars show the first frequency response curve (FRC 1) 
while closed bars show second frequency response curve (FRC 2) (n=10) in rat pressurized 
mesenteric arteries under raised tone conditions. Each bar represents mean ± standard error. 
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Fig. 6.5 (IIHFWV RI $ <0  ȝ0 Q 8), or NF449  ȝ0 (n=5) on responses to 
electrical field stimulation (0.5-10 Hz, 50 pulses, 10-20 V) in rat mesenteric arteries pressurized 
to 90 mmHg under raised tone conditions. Each bar represents mean ± standard error.* P < 
0.05, ** P < 0.01, *** P < 0.001 vs. control (ANOVA followed by Bonferroni post-hoc test). 
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Fig. 6.6 A) Representative trace showing application of exogenous NA (cumulative response 
curve) in the absence (basal tone conditions) and in the presence of U46619 (raised tone 
conditions) in rat mesenteric arteries pressurised to 90mmHg. B) Summary data of responses to 
NA (n=5), under basal tone conditions (control), and in the presence of U46619 (4-10 nM) in rat 
mesenteric arteries pressurized to 90 mmHg. Each bar represents mean ± standard error. *** P < 
0.001 vs. control (ANOVA followed by Bonferroni post-hoc test). 
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Fig. 6.7 A) Representative trace showing a VLQJOHDSSOLFDWLRQRIĮȕ-methyleneATP (0.1 µM), 
and in the absence (basal tone conditions) and in the presence of U46619 (raised tone 
conditions), in rat mesenteric arteries pressurised at 90 mmHg. B) Summary data of responses to 
Įȕ-methyleneATP (0.1 µM) (n=7) under basal tone conditions (control), and in the presence of 
U46619 (2-10 nM) in rat pressurized mesenteric arteries at 90 mmHg. Each bar represents mean 
± standard error. ** P < 0.01 vs. control 6WXGHQW¶VSDLUHGWWHVW 
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Fig. 6.8 Effects of Įȕ-methyleneATP (0.1 µM) (n=4), under basal tone conditions (control), 
and in the presence of U46619 (2-10 nM) in porcine small mesenteric arteries pressurized to 
90 mmHg. Each bar represents mean ± standard error. P > 0.05 (Mann Whitney test). 
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6.5 DISCUSSION 
The main finding of the present study is that in rat mesenteric arteries 
pressurised at 90 mmHg and pre-constricted with U46619, responses to 
electrically-HYRNHGDQGH[RJHQRXVO\DSSOLHG1$DQGĮȕ-methyleneATP were 
enhanced. Furthermore, both NA and ATP contributed in the mediation of the 
electrically-HYRNHG YDVRFRQVWULFWLRQ WKURXJK DFWLYDWLRQ RI Į1-adrenoceptors 
and P2X1 receptors respectively, under basal, and raised tone conditions. 
The aim of the present study was to investigate the sympathetic 
neurotransmission of isobarically mounted porcine mesenteric arteries using 
()6 8QIRUWXQDWHO\ WKLV ZDV QRW SRVVLEOH DOWKRXJK DSSOLFDWLRQ RI Įȕ-
methyleneATP evoked vasoconstrictor responses indicating that the vascular 
preparations were viable and contained P2X receptors. Furthermore, I 
demonstrated in chapter 5 that porcine mesenteric small arteries are rich in 
sympathetic perivascular nerves and responded to nerve activation when 
mounted on isometric myograph. In addition, it is unlikely that the lack of a 
response was due to technical limitations, since responses were obtained in 
similar sized rat mesenteric arteries (see below). Thus, it is surprising no 
responses were obtained to EFS in porcine mesenteric small arteries. It is 
possible that the difficulty in getting these vessels to form a tight seal in the 
suction electrode, because of the lack of fat and connective tissues that cover 
the vessels, may have impacted. 
1HYHUWKHOHVVĮȕ-methyleneATP evoked vasoconstrictor responses in porcine 
small mesenteric arteries under basal tone conditions. These vasoconstrictor 
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responses were enhanced in the presence of U46619. This is consistent with 
the results obtained in isometrically mounted porcine mesenteric small arteries 
(see chapter 5).  
In the absence of sustainable response to EFS in porcine tissue, I examined the 
effects of applying tone with U46619 in rat mesenteric arteries held under 
pressure since both mechanisms have been shown to enhance purinergic 
signalling in response to EFS (chapters 3, 4 and 5 and see Rummery et al). 
Under pressurised conditions (no tone), vasoconstrictor responses were 
sensitive to both YM-12617, a VHOHFWLYH Į1-adrenoceptor antagonist, and NF 
449, a selective P2X1 receptor antagonist. This indicates that both NA acting 
WKURXJKSRVWMXQFWLRQDOĮ1-adrenoceptors and ATP acting via P2X1 receptors are 
involved in mediating these responses.  
Under pressurised conditions (in the presence of tone), U46619 significantly 
enhanced the electrically-evoked vasoconstrictor responses. This has also been 
reported in human saphenous vein where U46619 enhanced responses to 
electrically-evoked vasoconstrictor responses (Vila et al., 2001), and is 
consistent with the results obtained in the porcine mesenteric small arteries 
(see chapter 5). Under these conditions, YM-12617 inhibited the electrically-
evoked vasoconstrictor responses indicating that NA is involved in the 
PHGLDWLRQ RI WKHVH UHVSRQVHV WKURXJK SRVWMXQFWLRQDO Į1-adrenoceptors. 
Furthermore, in the presence of U46619, NF 449 inhibited the electrically-
evoked vasoconstrictor responses indicating that ATP is involved in the 
mediation of the responses through P2X1 receptors. It should be noted that 
there was a slightly larger YM-12617-risistant component (purinergic 
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component) and NF 449-risistant component (noradrenergic component) in the 
presence of U46619 than that obtained under basal tone conditions. This may 
suggest that U46619 enhanced the YM-12617-resistant component (purinergic 
component) and NF 449-resistant component (noradrenergic component) 
which is consistent with the enhanced responses to the exogenous applications 
RI 1$ DQG Įȕ-methyleneATP in the presence of U46619 obtained in the 
present study. 
The mechanism by which U46619 enhanced electrically-evoked 
vasoconstrictor responses seems to be through a postjunctional mechanism, 
since U46619 enhanced responses to exogenously applied NA in the rat 
pressurised mesenteric arteries at 90 mmHg. This is consistent with the results 
of other experiments where U46619 enhanced responses to exogenously 
applied NA in human saphenous vein (Vila et al., 2001), and human umbilical 
vein (Errasti et al., 2007) and is consistent with the results obtained in the 
porcine mesenteric small arteries (see chapter 5). U46619 also enhanced 
UHVSRQVHVWRĮȕ-methyleneATP which is consistent with results obtained in the 
UDWSHUIXVHGDUWHULDOEHGZKHUHUHVSRQVHVWRĮȕ-methyleneATP were larger in 
pre-constricted preparations (Pakdeechote et al., 2007) and parallels my 
observation in porcine perfused arterial bed (see chapter 3). 
Although YM-12617 inhibited the response more than NF 449 especially at 
lower frequencies, both antagonists decreased responses by greater than 50% 
especially at higher frequencies under basal and raised tone conditions, 
indicating that NA and ATP may be acting synergistically. Synergism between 
NA and ATP has been reported in rat mesenteric arteries (Ralevic and 
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Burnstock, 1990). The mechanisms of synergism are not well understood. 
Nevertheless, it has been suggested that in the vas deferens smooth muscle NA 
potentiating the contractile responses to ATP by sensitising smooth muscle 
cells to calcium through the inhibition of myosin light chain phosphatase 
(Burnstock, 2004).  
Other studies of the native P2X1 receptor have used NF-449 at concentrations 
ranging from 1 to 10 µM (Kassack et al., 2004). Nevertheless the concentration 
of drug used in the present study caused a greater than 50% inhibition, thus it 
is unlikely a higher concentration would have altered the nature of the results 
obtained (i.e. a synergistic interaction between NA and ATP). 
In conclusion it seems that the combination of appropriate pressure and tone 
leads to an enhanced sympathetic response that is not mediated by a particular 
sympathetic neurotransmitter but by the involvement of both NA and ATP. 
ATP contributed to nerve-mediated vasoconstrictor responses in a synergistic 
way. U46619 enhances nerve-mediated responses and provides a synergistic 
stimulus for NA and ATP possibly through a postjunctional mechanism. 
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7 GENERAL DISCUSSION 
An important role for ATP as a sympathetic neurotransmitter is known. 
However, the relative importance of ATP as a functional sympathetic 
neurotransmitter in blood vessels has been shown to be variable. This 
variability occurs due to a number of factors including species, vascular bed, 
size of blood vessel and the level of pre-existing vascular tone (Ralevic, 2009). 
Vascular tone reflects the degree of constriction the blood vessels experiences 
relative to its maximally dilated state under basal tone conditions. 
Nevertheless, in most studies consideration of vascular tone is absent. Recent 
studies showed that in the rat perfused mesenteric bed in which vascular tone 
was raised using U46619, ATP became an important functional sympathetic 
neurotransmitter (Pakdeechote et al., 2007). The current study investigated if 
raised vascular tone would reveal a functional role for ATP as a sympathetic 
neurotransmitter in porcine perfused mesenteric bed and isolated mesenteric 
arteries, and demonstrated this to be the case. 
One of the important observations in this study was that enhanced contractile 
responses to EFS were obtained under conditions of raised tone induced by 
U46619. This enhancement was evident in the porcine perfused vascular bed 
and in isometrically mounted porcine mesenteric arteries of different sizes. To 
further investigate the nature of the electrically-evoked contractile responses I 
examined the responses during Į1-adrenocetor and/or P2X receptor blockade 
and showed that they were mediated solely by NA via the activation of 
SRVWMXQFWLRQDOĮ1-adrenocetors under conditions of basal tone. Similar results 
have been reported in the isolated perfused mesentery of the rat (Williams and 
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Clarke, 1995, Pakdeechote et al., 2007). Conversely, raising tone with U46619 
revealed that these responses were partially mediated by ATP through the 
activation of P2X receptors. This observation was evident in the perfused 
vascular bed and in isolated arteries of different sizes. Thus, raising tone with 
U46619 enhanced the purinergic response and as a consequence the whole 
response was enhanced.  
Further investigations showed that the purinergic response was enhanced under 
conditions of raised tone via a postjunctional mechanism since responses to the 
analogue of ATP, Įȕ-methyleneATP, were enhanced under conditions of 
raised tone in the perfused bed and isometrically mounted arteries of different 
sizes. Furthermore, the enhancement of the purinergic response seems to be a 
consequence of raising the tone regardless of the agent used to induce the tone, 
VLQFH HQKDQFHG UHVSRQVHV WR Įȕ-methyleneATP were also obtained in the 
presence of ET-1. It has been shown that U46619 depolarizes vascular smooth 
muscle (Crane and Garland, 2004, Shaw et al., 2004). Thus, any depolarization 
caused by U46619 may provide the conditions where further depolarization 
caused by ATP acting on P2X receptors results in a more substantial opening 
of Ca2+ channels and a contraction (Pakdeechote et al., 2007). Some data 
obtained in the present study supports this suggestion since nifedipine 
attenuated UHVSRQVHVHYRNHGE\()6DQGĮȕ-methyleneATP under raised tone 
condition but not under basal tone conditions.  
An enhancement of the electrically-evoked contractile responses through the 
enhancement of the noradrenergic component of the sympathetic response 
under conditions of raised tone may also occur although this was hard to define 
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for several reasons. Firstly, NA was the major neurotransmitter under basal 
and raised tone conditions, thus making it difficult to define an enhanced 
response although responses to exogenous NA were potentiated with U46619. 
Secondly, electrically-HYRNHG 1$ PD\ DFW QRW RQO\ RQ Į1-adrenoceptors but 
DOVR RQ SRVWMXQFWLRQDO Į2-DGUHQRFHSWRUV DQG SUHMXQFWLRQDO Į2-adrenoceptors 
which are known to inhibit the release of NA may cause underestimation of 
postjunctional inhibition.  
Another mechanism by which U46619 may enhance the contractile responses 
is by increasing the myofilament Ca2+ sensitivity in vascular smooth muscles 
(Ungvari and Koller, 2000, Ding and Murray, 2005). However, data obtained 
in the current study showed that nifedipine inhibited the enhanced electrically-
HYRNHG FRQWUDFWLOH UHVSRQVHV DQG WKH HQKDQFHG UHVSRQVHV WR H[RJHQRXV Įȕ-
methyleneATP. Thus the enhanced responses required entry of extracellular 
Ca2+ through the L-type calcium channels. Moreover, Įȕ-methyleneATP 
inhibited the enhanced responses indicating that extracellular calcium entry via 
P2X receptors was required. Thus our data show that the enhanced responses 
appeared to utilize calcium mainly extracellular rather than from intrarcellular 
stores. However, there is a possibility that calcium entering via P2X receptors 
or/and calcium-sensitive channels may activate the calcium-induced calcium 
release mechanism which clearly needs further investigations. 
Although data obtained in this study indicate a postjunctional mechanism of 
enhancement of the electrically-evoked contractile responses a prejunctional 
mechanism cannot be excluded. The use of new methods such as the Ca2+ 
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confocal imaging (Brain, 2009, Wier et al., 2009) would be useful in further 
investigations of the release of NA and ATP in future studies. 
It is well known that smaller arteries are more involved in the control of blood 
pressure than large conduct arteries. It has been reported that the density of 
P2X receptors is larger as the size of blood vessels decreases in the rat 
mesenteric vascular bed (Gitterman and Evans, 2000). Furthermore, an 
increasing role for P2X receptors in mediating electrically-evoked contractile 
responses in rat mesenteric arteries as the size of blood vessels decreases has 
also been shown (Gitterman and Evans, 2001). In this study I demonstrated 
WKDW UHVSRQVHV WR Įȕ-methyleneATP were more prominent in porcine small 
arteries than those in larger arteries. Moreover, the purinergic component of 
EFS seems to be larger in porcine small arteries than in larger arteries. 
However, the purinergic component of the contractile responses to EFS was 
evident only under the conditions of raised tone, and seemed modest if 
compared to that obtained in the study of Gitterman and Evans (2001) in rat 
mesenteric arteries. Thus, data obtained in this study seems to be in agreement 
with a growing consensus that the purinergic component of the sympathetic 
neurotransmission increases as the size of vessel decreases. The revelation that 
ATP has a prominent functional role in these arteries highlights the potential 
importance of ATP in the regulation of blood pressure. 
It has been reported that isobarically mounted rabbit mesenteric arteries were 
more sensitive to physiological concentrations of agonists than when they were 
isometrically mounted (Dunn et al., 1994). In addition, increasing the 
7. General discussion 
164 
 
made responses larger and revealed a predominant functional role for ATP as 
the sympathetic neurotransmitter in rat mesenteric arteries (Rummery et al., 
2007). Furthermore, data obtained in this study showed that contractile 
responses in vessels exposed to pressure in porcine perfused mesenteric bed 
are enhanced more than those in isometrically mounted arteries. It has also 
been previously reported that increasing pressure depolarizes vascular smooth 
muscle and increases the amplitude of the excitatory junctional potential 
(Rummery et al., 2007). Raising vascular tone enhanced the electrically-
evoked contractile responses of the rat perfused mesenteric bed (Pakdeechote 
et al., 2007) and porcine mesentery (this thesis). Thus, I investigated the effects 
of exposing rat small mesenteric arteries to the combined effects of pressure 
(close to that experienced in vivo which is approximately between 80 and 115 
mmHg (Rummery et al., 2007)) and a degree of pre-constriction (tone), and 
showed an enhancement of the electrically-evoked vasocontractile responses. 
Under basal tone conditions, further investigations in rat pressurised 
mesenteric arteries showed that the electrically-evoked vasocontractile 
responses were sensitive to the VHOHFWLYH Į1-adrenoceptor antagonist, YM-
12617, as well as to the selective P2X1 receptor antagonist, NF 449. This 
indicates that both NA DFWLQJWKURXJKSRVWMXQFWLRQDOĮ1-adrenoceptor and ATP 
acting via P2X1 receptors are involved in mediating these responses.  
Under conditions of raised tone with U46619, the electrically-evoked 
vasocontractile responses were enhanced. However, further investigations 
showed that enhanced vasocontractile responses were not mediated by a 
particular sympathetic neurotransmitter but by the involvement of both NA and 
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ATP. Furthermore UHVSRQVHV WR H[RJHQRXV 1$ DQG Įȕ-methyleneATP were 
also enhanced in pressurised arteries under raised tone conditions suggesting a 
postjunctional mechanism of enhancement. These results clearly demonstrated 
an important role for ATP as a sympathetic neurotransmitter provided similar 
conditions of tone and pressure to those experienced in vivo are considered. 
The association of increased blood pressure and role for ATP as a sympathetic 
neurotransmitter has also been demonstrated in animal models of hypertension. 
For example, in tail arteries of spontaneous hypertensive rat (SHR) a 
dominance of the purinergic component of the sympathetic response has been 
reported (Vidal et al., 1986))XUWKHUPRUHDQLQFUHDVHGUHVSRQVLYHQHVVWRĮȕ-
methyleneATP in the blood vessels of SHR perfused kidneys has been shown 
(Fernandez et al., 2000). In addition, contractile responses to ATP were 
enhanced in SHR aorta (Yang et al., 2004). Thus, it seems that data obtained in 
this study are in agreement with the growing evidence on the involvement of 
ATP as a functional sympathetic neurotransmitter both in animal models of 
hypertension and in experiments where the conditions of pressure and tone are 
similar to that experienced in vivo. 
In summary, this study demonstrated that under conditions of basal tone NA 
was the main neurotransmitter mediating the electrically-evoked contractile 
responses in the porcine perfused whole mesenteric and in porcine mesenteric 
arteries of different sizes. Conversely, when tone was raised ATP contributed 
as a functional sympathetic neurotransmitter in the mediation of the responses. 
This contribution seems to be more evident as the size of the blood vessel 
decreases. In rat mesenteric arteries pressurised close to physiological levels 
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and exposed to pre-constriction ATP and NA both contributed in the mediation 
of the electrically-evoked contractile responses. These results could have 
important implications for our understanding of the sympathetic control of 
blood vessels and elevated blood pressure that occurs in hypertension. 
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